Mindspeed Technologies, a bold leader in advanced semiconductor technologies for network/communications infrastructure, reported today that the ingenuous small-cell strategy (specifically for data offload) developed in conjunction with SK Telecom and Contela, essentially the world’s first data-only femtocell service engineered to meet the emergent demands of a growing smartphone/tablet space, has successful won the Small Cell Industry Award for Commercial Deployment (Innovation in Commercial Deployment) at this year’s Small Cell World Summit in London. The Summit is influential because the panel is comprised of senior telecom professionals chosen for the depth of their experience and impartiality.
This is a huge boon for Mindspeed, whose low-power SoC (system-on-chip) architectures have won acclaim throughout the industry in recent years for driving blisteringly fast video, voice, and data capabilities. With a bevy of robust analog products for fiber optic, enterprise, industrial, and video transport solutions, MSPD is a key part of the lifeblood of many global OEMs, bringing the kind of hardcore processing muscle needed to support rapidly evolving 3G and LTE (long-term evolution) mobile networks.
In fact, Mindspeed has become a central feature of the SoC landscape, with around 70% market share in the HSPA space (according to ABI Research), and some 25 LTE design partnering with the likes of such prominent sector players as AirWalk Communications, Juni, Powerwave Technologies, Inc., and Tektelic Communications (in addition to SK Telecom and Contela). As the only small cell SoC developer offering full support for HSPA and LTE (also the only company to have demonstrated frequency-division duplexing, aka FDD, and time-division, aka TD-LTE, solutions), MSPD is further cemented into the horizon of the entire small cell space with today’s announcement and the company was the only baseband silicon developer to win an award this year.
The most exciting thing about the win is that five other winners this year in other categories all featured MSPD technology under the hood, with the winner of the Enabling Technology category (and MPSD partner), Radisys Corp’s Trillium® TOTALeNodeB software platform (which helped make the LTE small cells from Juni and Dongwon produced for Korea Telecom possible), showcasing the raw power of Mindspeed’s baseband processors (upon which the LTE cells were built).
This incredible relationship strategy that MSPD has developed is the real story. Looking at the results from the Small Cell World Summit, we can see how the company’s management has shrewdly enmeshed their technology into the larger market pipeline.
CTO for SK Telecom, Byun Jae-Woan, hailed this award as signaling another milestone on the road to realizing the companies shared vision for bringing consumers a “convenient and flawless wireless data service,” based on bleeding-edge femtocell technologies.
CEO of MSPD, Raouf Halim, underscored the company’s technology being at the heart of multiple winners at the Summit as a clear sign of rigorous independent validation of the company’s portfolio in the small cell space. Pointing to Korea as being first to market with next-gen 4G LTE small cell technologies, Halim argued that the company’s offerings were exceptionally well-timed with regard to the exploding, exponential data traffic demands placed on mobile frameworks as tablets and smartphones become more ubiquitous. Halim also stressed the importance of this collaboration with Contela and SK Telecom as the first ever, data offload-centric, small cell solution.
Mindspeed has in excess of 40 W-CDMA (wideband code division multiple access) design engagements, in addition to six key time division synchronous code division multiple access (TD-SCDMA) femtocell/picocell products that are all designed to meet the complex needs of a well-defined target market. With this kind of technical prowess, it is no wonder that MSPD had such a good showing at this year’s Small Cell World Summit.
It’s perfect really, ultra-modern small cell platforms driving the best in class software solutions, exactly what is needed to compensate for the bandwidth glut of ever increasing data flows.
For more information, or to check out the joint-hosted webinar between Mindspeed and Radisys on small cell tech and the rapidly growing global infrastructure of deployed hardware/software (June 29), head over to the Mindspeed Technologies, Inc. website at: www.MindSpeed.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, June 29, 2012
Telanetix, Inc. (TNIX) is “One to Watch”
Telanetix has quickly risen to a position of prominence in the hosted communications sector via the company’s AccessLine™ brand of cloud-based telecom voice services, featuring the latest in sophisticated VoIP solutions for any business. The company is there for customers with a full suite of integrated communications technologies, dedicated to enhancing hardware solutions via SaaS (software as a service) applications provided over a hosted global network, making the ultimate telecom value proposition accessible to the widest range of businesses.
Whether the client is an executive who is constantly on the go, a sales force that is going nuts trying to maintain multiple points of phone contact, or an office manager seeking to deploy a serious, professional-grade phone system that matches real-world demands (but at a small business price), TNIX is able to deliver a comprehensive solution.
One look at the digital business phone service developed by TNIX is all it takes to understand how the company has achieved this level of success, serving in excess of 100k clients (including heavy hitters like American Express, IBM, and Sun Microsystems) with this powerful combination of state of the art small business PBX phone systems and the company’s hosted voice services. With the help of Telanetix’s digital phone service, even small companies can easily migrate to more efficient infrastructure, avoiding the massive overhead associated with installing a new, costly phone system and eliminating the need to have an IT professional on the payroll to handle the process.
In one fell swoop, even small businesses can quickly replace existing PBX/voicemail infrastructure without having to fork over big capital outlays to do so, while also obtaining the many benefits provided within the new solution, like virtualizing the extensions and contact points for maximum scalability (and maximum national/international presence). Total end-user call control/management capabilities are included, as well as the capacity to extend corporate dial plans and the advanced feature set to employees at any phone or desktop, all within an integrated services envelope that meshes seamlessly with existing landline, wireless, and existing corporate networks.
We are talking total, unified messaging here that allows for crystal clear external business continuity; solutions that make the telecommuting and mobile workforce targets accessible, even on a small budget. Telanetix has aggressively pursued a dynamic partnering strategy with other top VoIP and telephony carriers to create a single umbrella that covers all the bases, whether you are in the office on the corporate VPN or in the field working with clients, AccessLine provides Fortune 50 class execution at small business prices.
Key emphasis on interoperability and dovetailing with legacy systems makes moving to the next level with phone services a breeze and a simple decision for managers. Easy to understand, easy to implement, and ruthlessly efficient at virtualizing a constantly changing demand space for the ultimate in continuity and user-control, this is the image of the AccessLine brand that has quickly disseminated sector-wide with each client success story. The company even extends a generous referral rewards program, whereby customers who submit a referral can get back $50 per line on digital phone system and service package purchases ($25 on referrals who purchase individual services).
Services like SmartConference, which bundles everything from a full web interface, guest codes, scheduling, and all the other bells and whistles clients need to execute professional conferencing, are also available without any hidden fees or annual contacts. Smart800, a flat rate toll-free number system offers a variety of choices in addition to the basic free set up and activation version, with custom vanity numbers and even existing number transfers. SmartMessage, a unified fax and voice mail platform, propagates emails or text messages to alert users of a new voice mail or fax. SmartOffice, super easy to use, set up, and configure via a web interface, gives full auto attendant capabilities (a virtual attendant that greets callers and provides menu options) to callers (sample scripts are even provided for custom menu options) and eliminates phone tag by instantly routing any/all calls to any location.
The AccessLine SIP Trunking technology at the heart of their solutions (with or without a VoIP gateway) brings so many new features to the table it’s hard to imagine doing business without them. With enhanced features like a virtual web-fax service that allows web-based send/receive, follow-me-number capability which automatically routes calls to devices in order to make sure a call is never missed, and even hunt groups (allows inbound/outbound calls to automatically hunt for the next available line) makes jumping ship from existing backend infrastructure a mo-brainer.
Keep all the phones and just replace the backend with VoIP; do it simply, easily, and without huge capital outlays, and end up with a telecommunications solution that offers total end-user control and system-wide, real-time situational awareness – this is what today’s competitive businesses are thinking, and TNIX has the goods to make it a reality. All of the installation, management, and support activities required are handled directly by certified AccessLine technicians and the company really cares about working hand-in-hand with clients to achieve a unique, customized solution that fits the real-world demands of the business. Full technical support from AccessLine’s award winning customer service group supports big clients (like Sun and IBM) just as well as small businesses and entrepreneurs.
Being able to bring in a comprehensive overlay system like this through advanced VoIP technology creates workflow synergies that are immediately applied to the bottom line. The time saving and cost saving potential of such solutions has become increasingly more attractive as the globalized, virtualized workspace comes increasingly to the fore.
For more information on Telanetix Inc. please visit the company’s website at: www.AccessLine.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Whether the client is an executive who is constantly on the go, a sales force that is going nuts trying to maintain multiple points of phone contact, or an office manager seeking to deploy a serious, professional-grade phone system that matches real-world demands (but at a small business price), TNIX is able to deliver a comprehensive solution.
One look at the digital business phone service developed by TNIX is all it takes to understand how the company has achieved this level of success, serving in excess of 100k clients (including heavy hitters like American Express, IBM, and Sun Microsystems) with this powerful combination of state of the art small business PBX phone systems and the company’s hosted voice services. With the help of Telanetix’s digital phone service, even small companies can easily migrate to more efficient infrastructure, avoiding the massive overhead associated with installing a new, costly phone system and eliminating the need to have an IT professional on the payroll to handle the process.
In one fell swoop, even small businesses can quickly replace existing PBX/voicemail infrastructure without having to fork over big capital outlays to do so, while also obtaining the many benefits provided within the new solution, like virtualizing the extensions and contact points for maximum scalability (and maximum national/international presence). Total end-user call control/management capabilities are included, as well as the capacity to extend corporate dial plans and the advanced feature set to employees at any phone or desktop, all within an integrated services envelope that meshes seamlessly with existing landline, wireless, and existing corporate networks.
We are talking total, unified messaging here that allows for crystal clear external business continuity; solutions that make the telecommuting and mobile workforce targets accessible, even on a small budget. Telanetix has aggressively pursued a dynamic partnering strategy with other top VoIP and telephony carriers to create a single umbrella that covers all the bases, whether you are in the office on the corporate VPN or in the field working with clients, AccessLine provides Fortune 50 class execution at small business prices.
Key emphasis on interoperability and dovetailing with legacy systems makes moving to the next level with phone services a breeze and a simple decision for managers. Easy to understand, easy to implement, and ruthlessly efficient at virtualizing a constantly changing demand space for the ultimate in continuity and user-control, this is the image of the AccessLine brand that has quickly disseminated sector-wide with each client success story. The company even extends a generous referral rewards program, whereby customers who submit a referral can get back $50 per line on digital phone system and service package purchases ($25 on referrals who purchase individual services).
Services like SmartConference, which bundles everything from a full web interface, guest codes, scheduling, and all the other bells and whistles clients need to execute professional conferencing, are also available without any hidden fees or annual contacts. Smart800, a flat rate toll-free number system offers a variety of choices in addition to the basic free set up and activation version, with custom vanity numbers and even existing number transfers. SmartMessage, a unified fax and voice mail platform, propagates emails or text messages to alert users of a new voice mail or fax. SmartOffice, super easy to use, set up, and configure via a web interface, gives full auto attendant capabilities (a virtual attendant that greets callers and provides menu options) to callers (sample scripts are even provided for custom menu options) and eliminates phone tag by instantly routing any/all calls to any location.
The AccessLine SIP Trunking technology at the heart of their solutions (with or without a VoIP gateway) brings so many new features to the table it’s hard to imagine doing business without them. With enhanced features like a virtual web-fax service that allows web-based send/receive, follow-me-number capability which automatically routes calls to devices in order to make sure a call is never missed, and even hunt groups (allows inbound/outbound calls to automatically hunt for the next available line) makes jumping ship from existing backend infrastructure a mo-brainer.
Keep all the phones and just replace the backend with VoIP; do it simply, easily, and without huge capital outlays, and end up with a telecommunications solution that offers total end-user control and system-wide, real-time situational awareness – this is what today’s competitive businesses are thinking, and TNIX has the goods to make it a reality. All of the installation, management, and support activities required are handled directly by certified AccessLine technicians and the company really cares about working hand-in-hand with clients to achieve a unique, customized solution that fits the real-world demands of the business. Full technical support from AccessLine’s award winning customer service group supports big clients (like Sun and IBM) just as well as small businesses and entrepreneurs.
Being able to bring in a comprehensive overlay system like this through advanced VoIP technology creates workflow synergies that are immediately applied to the bottom line. The time saving and cost saving potential of such solutions has become increasingly more attractive as the globalized, virtualized workspace comes increasingly to the fore.
For more information on Telanetix Inc. please visit the company’s website at: www.AccessLine.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
GSA Advances Green Power Adoption and Significant Energy Savings through World Energy Solutions, Inc. (XWES)
World Energy Solutions, a prominent energy management services firm, announced that it has assisted the U.S. General Services Administration, Region 2, in the procurement of approximately 300 million kWh of electricity. The procurement includes multiple GSA facilities in New York, in addition to other federal accounts, including the American Red Cross, Bureau of Prisons, United Nations, U.S. Coast Guard, and U.S. Department of Veterans Affairs.
In a battery of competitive online auctions on the World Energy Exchange ®, GSA tested several products and terms in a reasonable and transparent manner, accumulating 127 bids from six suppliers throughout the process. The auctions brought in new contracts that are expected to result in over $10.8 million in savings relative to the prior agreements of the participating agencies. Delivery will begin in May 2012 under the new terms.
Markedly, GSA awarded two-year power contracts for its Manhattan and Upstate Service Centers. It is anticipated that these contracts will result in annual savings in excess of $3 million and $750,000. The Manhattan Service Center was able to achieve savings of this magnitude while purchasing exclusively green energy. Additionally, GSA’s Upstate Service Center was able to up its green energy percentage to 7.5% from its previous value of 0%.
Through the auctions, each participating agency secured green power while reducing energy costs, further burnishing GSA Region 2′s credentials in environmental leadership. In 2011, GSA Region 2 won a coveted GSA Achievement Award for Real Property Innovation in sustainability. GSA has been notified it will receive a similar award again in 2012 for continuing to lead by example.
“It is very gratifying to help GSA Region 2 and other participating federal agencies in New York capitalize on historic lows in the market to save money and green their portfolios,” said Jonathan Harvey, Vice President, Government, at World Energy Solutions. “Each time we do this — and we’ve been working together now for 10+ years — we see how well our procurement process works, the competitive dynamics it fosters and the strong supplier participation it elicits. GSA continues to lead the way in energy procurement, delivering great results to its constituents in a fair and transparent manner.”
Added Phil Adams, CEO of World Energy Solutions: “Under the careful stewardship of Ken Shutika and Brian Magden, GSA Region 2 has set the gold standard for energy procurement. The proof lies in the numerous awards they have won — and keep on winning — and the millions of dollars in electricity-rate savings and green power they continue delivering to a growing number of federal agencies and facilities.”
Yesterday’s deal marks the latest success for World Energy and GSA under the terms of a 5-year energy management contract the two executed in 2010. That contract provides supply-side energy procurement and management services to the GSA’s Energy Division for its extensive network of federal government agencies and runs through September 30, 2015.
For further information, please visit www.worldenergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
In a battery of competitive online auctions on the World Energy Exchange ®, GSA tested several products and terms in a reasonable and transparent manner, accumulating 127 bids from six suppliers throughout the process. The auctions brought in new contracts that are expected to result in over $10.8 million in savings relative to the prior agreements of the participating agencies. Delivery will begin in May 2012 under the new terms.
Markedly, GSA awarded two-year power contracts for its Manhattan and Upstate Service Centers. It is anticipated that these contracts will result in annual savings in excess of $3 million and $750,000. The Manhattan Service Center was able to achieve savings of this magnitude while purchasing exclusively green energy. Additionally, GSA’s Upstate Service Center was able to up its green energy percentage to 7.5% from its previous value of 0%.
Through the auctions, each participating agency secured green power while reducing energy costs, further burnishing GSA Region 2′s credentials in environmental leadership. In 2011, GSA Region 2 won a coveted GSA Achievement Award for Real Property Innovation in sustainability. GSA has been notified it will receive a similar award again in 2012 for continuing to lead by example.
“It is very gratifying to help GSA Region 2 and other participating federal agencies in New York capitalize on historic lows in the market to save money and green their portfolios,” said Jonathan Harvey, Vice President, Government, at World Energy Solutions. “Each time we do this — and we’ve been working together now for 10+ years — we see how well our procurement process works, the competitive dynamics it fosters and the strong supplier participation it elicits. GSA continues to lead the way in energy procurement, delivering great results to its constituents in a fair and transparent manner.”
Added Phil Adams, CEO of World Energy Solutions: “Under the careful stewardship of Ken Shutika and Brian Magden, GSA Region 2 has set the gold standard for energy procurement. The proof lies in the numerous awards they have won — and keep on winning — and the millions of dollars in electricity-rate savings and green power they continue delivering to a growing number of federal agencies and facilities.”
Yesterday’s deal marks the latest success for World Energy and GSA under the terms of a 5-year energy management contract the two executed in 2010. That contract provides supply-side energy procurement and management services to the GSA’s Energy Division for its extensive network of federal government agencies and runs through September 30, 2015.
For further information, please visit www.worldenergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Emmis Communications Corp. (EMMS) Selects TuneIn to Broaden Market Reach
Yesterday, TuneIn announced that it has been selected by Emmis Communications to broaden the reach of its 20 stations to the service’s 30 million monthly active listeners. As part of the agreement, Emmis will gain use of a variety of TuneIn tools, such as free analytics and an ad platform. Emmis stations will also promote TuneIn to their listeners on-air.
“One of our key focal points is to connect the highest quality broadcasters with the millions of passionate listeners who look to TuneIn to hear their favorite content and discover great new stations and artists,” said John Donham, CEO, TuneIn. “Emmis has such a compelling stable of influential radio stations, and as an organization they really understand the value of great programming and strong brand-building. We are very excited to align with them.”
Emmis owns and operates radio stations in the nation’s largest markets, including New York, Los Angeles, Austin, St. Louis, and Indianapolis, its hometown. TuneIn listeners now can enjoy popular Emmis stations through over 150 different platforms, including smartphone and tablet apps, connected vehicle dashboards, Internet home entertainment systems, and online at www.tunein.com. Currently, TuneIn Radio and TuneIn Radio Pro are the only audio streaming apps that have a 4.5 or 5 star rating on every mobile platform, worldwide.
Jeff Smulyan, Chairman and CEO of Emmis Communications, remarked, “Emmis is excited by today’s announcement. We want to follow our listeners and deliver our content to the platforms they choose to use. The TuneIn platform will provide our listeners from coast to coast another connection point with their favorite radio brands.”
Signs of the alliance were evident earlier this month when Emmis offered the entire HOT 97 Summer Jam festival available for free through TuneIn’s service. Emmis also offered theme stations celebrating the music of HOT 97 Summer Jam and the POWER 106 Powerhouse festival exclusively to TuneIn listeners. TuneIn and Emmis-owned KGSR/Austin worked closely together in March as KGSR streamed numerous live performances from SXSW to the TuneIn audience.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“One of our key focal points is to connect the highest quality broadcasters with the millions of passionate listeners who look to TuneIn to hear their favorite content and discover great new stations and artists,” said John Donham, CEO, TuneIn. “Emmis has such a compelling stable of influential radio stations, and as an organization they really understand the value of great programming and strong brand-building. We are very excited to align with them.”
Emmis owns and operates radio stations in the nation’s largest markets, including New York, Los Angeles, Austin, St. Louis, and Indianapolis, its hometown. TuneIn listeners now can enjoy popular Emmis stations through over 150 different platforms, including smartphone and tablet apps, connected vehicle dashboards, Internet home entertainment systems, and online at www.tunein.com. Currently, TuneIn Radio and TuneIn Radio Pro are the only audio streaming apps that have a 4.5 or 5 star rating on every mobile platform, worldwide.
Jeff Smulyan, Chairman and CEO of Emmis Communications, remarked, “Emmis is excited by today’s announcement. We want to follow our listeners and deliver our content to the platforms they choose to use. The TuneIn platform will provide our listeners from coast to coast another connection point with their favorite radio brands.”
Signs of the alliance were evident earlier this month when Emmis offered the entire HOT 97 Summer Jam festival available for free through TuneIn’s service. Emmis also offered theme stations celebrating the music of HOT 97 Summer Jam and the POWER 106 Powerhouse festival exclusively to TuneIn listeners. TuneIn and Emmis-owned KGSR/Austin worked closely together in March as KGSR streamed numerous live performances from SXSW to the TuneIn audience.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Lantronix, Inc. (LTRX) & OKI Co-Market iOS xPrintServer
Lantronix recently announced that it would be joining with OKI Data Americas to co-market its xPrintServer group of iOS print server hardware. OKI is Lantronix’s first such partner.
Lantronix, based in Irvine, CA, is focused on secure communication technologies that simplify access and communication with and between electronic devices, and sharing data between devices that connect electronic equipment via networks and the Internet. The company’s xPrintServer uses the native print menu in iOS, without other software, to wirelessly print from any iOS device running iOS 4.2 or later.
Operating under the assumption that iPad use is expected to double during 2012, and overall adoption of the platform growing in educational and enterprise markets, OKI will be referring the xPrintServer line to its network of customers and distributors. In return, Lantronix will refer OKI’s products to members of its network that are in need of customized printing solutions.
Mark D. Tullio, vice president of worldwide marketing for Lantronix, said, “OKI is a leader in the printer space and has already proven to be an outstanding sales, distribution and marketing partner. With our technology and OKI’s track record of developing innovative printing solutions, we anticipate even more co-marketing and promotional opportunities over the coming year.”
Keith Fenton, product planning manager — MFP Software and Solutions at OKI Data Americas, said, “The Lantronix xPrintServer offers a compelling value proposition for OKI in the mobile printing arena. Every day, more and more customers are demanding iOS printing solutions — not just for new printers and multi-function devices, but for legacy equipment as well. From its slick design to its incredible ease-of-use, the Lantronix xPrintServer is an affordable and viable mobile printing solution.”
More information can be obtained at www.lantronix.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Lantronix, based in Irvine, CA, is focused on secure communication technologies that simplify access and communication with and between electronic devices, and sharing data between devices that connect electronic equipment via networks and the Internet. The company’s xPrintServer uses the native print menu in iOS, without other software, to wirelessly print from any iOS device running iOS 4.2 or later.
Operating under the assumption that iPad use is expected to double during 2012, and overall adoption of the platform growing in educational and enterprise markets, OKI will be referring the xPrintServer line to its network of customers and distributors. In return, Lantronix will refer OKI’s products to members of its network that are in need of customized printing solutions.
Mark D. Tullio, vice president of worldwide marketing for Lantronix, said, “OKI is a leader in the printer space and has already proven to be an outstanding sales, distribution and marketing partner. With our technology and OKI’s track record of developing innovative printing solutions, we anticipate even more co-marketing and promotional opportunities over the coming year.”
Keith Fenton, product planning manager — MFP Software and Solutions at OKI Data Americas, said, “The Lantronix xPrintServer offers a compelling value proposition for OKI in the mobile printing arena. Every day, more and more customers are demanding iOS printing solutions — not just for new printers and multi-function devices, but for legacy equipment as well. From its slick design to its incredible ease-of-use, the Lantronix xPrintServer is an affordable and viable mobile printing solution.”
More information can be obtained at www.lantronix.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
A123 Systems, Inc. (AONE) Video Chart for Friday, June 29, 2012
AONE bounced about 100 percent since forming a multiple bottom just above 80 cents. The share price is retracing, but approaching a key support level that technical traders will be looking to hold for the chart to maintain a solid uptrend. Resistance is sitting ahead between $1.50 and $1.60 cents.
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
SEFE, Inc. (SEFE) Offers Amazingly Efficient Renewable Energy
Almost every aspect of the renewable energy industry – wind, solar, biomass, and others – revolves around electricity. Wind power generates electricity from the wind. Active solar generates electricity from sunlight. Biomass . . . well, you get the picture. One of the problems with it all is the inefficiency inherent in the generation of electricity. When you turn wind into electricity, you lose part of the energy in the process. The same is true of solar and biomass. Even hydroelectricity, the grandfather of renewables, pays a price for inefficiency. Capturing energy and then transforming it into a new form is simply not a perfect process.
It’s a problem not shared with the totally new and innovative approach to energy generation being developed by SEFE, Inc., a Colorado-based renewable energy company. SEFE has come up with a brand new way to tap raw electrical energy directly from the earth’s atmosphere. This is energy that is always available. It’s energy that is already in the form of electricity, electrical energy that is readily convertible to alternating current at the necessary voltages. The concept, together with the technologies that are rapidly turning it into a working reality, are revolutionary enough to already be the subject of 22 patent filings by SEFE, 4 of which have been granted, with 18 still pending approval.
Another major inefficiency comes into play with the storage of electricity, a necessity when using a system that generates electricity irregularly and independent of the need. The sun shines during the day, but part of the electricity it generates is needed at night, and the wind blows independently of electrical demand. All sorts of ways have been used to capture and hold that generated power until it is needed, but all of them lose something in the bargain.
Again, SEFE has the advantage. SEFE’s remarkable system can capture electrical energy from the atmosphere any time of the day or night, in virtually any weather, and in any location. It’s as if the entire atmosphere were a giant battery, waiting to be tapped. As a result, there is less need to worry about electrical storage and all of the inefficiencies and costs that involves. That’s why the SEFE system is expected to be amazingly cost effective in its final form, beating out solar and wind.
For additional information, visit the company’s websites at www.SEFElectric.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
It’s a problem not shared with the totally new and innovative approach to energy generation being developed by SEFE, Inc., a Colorado-based renewable energy company. SEFE has come up with a brand new way to tap raw electrical energy directly from the earth’s atmosphere. This is energy that is always available. It’s energy that is already in the form of electricity, electrical energy that is readily convertible to alternating current at the necessary voltages. The concept, together with the technologies that are rapidly turning it into a working reality, are revolutionary enough to already be the subject of 22 patent filings by SEFE, 4 of which have been granted, with 18 still pending approval.
Another major inefficiency comes into play with the storage of electricity, a necessity when using a system that generates electricity irregularly and independent of the need. The sun shines during the day, but part of the electricity it generates is needed at night, and the wind blows independently of electrical demand. All sorts of ways have been used to capture and hold that generated power until it is needed, but all of them lose something in the bargain.
Again, SEFE has the advantage. SEFE’s remarkable system can capture electrical energy from the atmosphere any time of the day or night, in virtually any weather, and in any location. It’s as if the entire atmosphere were a giant battery, waiting to be tapped. As a result, there is less need to worry about electrical storage and all of the inefficiencies and costs that involves. That’s why the SEFE system is expected to be amazingly cost effective in its final form, beating out solar and wind.
For additional information, visit the company’s websites at www.SEFElectric.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
FluoroPharma Medical, Inc. (FPMI) Targets #1 Most Wanted
In 1950, the FBI formally announced their Ten Most Wanted list to the world, in an attempt to promote the identification and capture of the most notorious fugitives. If there were a ten most wanted health list, coronary artery disease (CAD), still the world’s #1 killer, would be at the top. Several million people die every year from CAD. In the U.S., it is responsible for approximately one third of all deaths. It’s little wonder that the health industry is gunning for CAD in a big way.
However, in spite of huge investments in drugs to fight the disease, it is becoming clear that drugs cannot cure coronary artery disease. Although progress has been made in reducing LDL (sometimes called the “bad” cholesterol, a risk factor for CAD), the fact remains that up to 35% of heart attack patients do not have high blood cholesterol levels, even though most of them have atherosclerosis (hardening of the arteries). In addition, attempts to use drugs to raise the level of HDL (“good” cholesterol) have proven unsuccessful.
The best weapon to use against CAD remains early diagnosis and diagnostic follow-up, using sophisticated technologies such as positron emission tomography (PET) scanning, the best technology for detecting the subtle biological processes associated with CAD and other diseases. And this is exactly the market targeted by FluoroPharma Medical, developers of advanced tracer chemicals needed to make PET effective. FluoroPharma’s two lead products are CardioPET, used for the assessment of myocardial metabolism, and BFPET, used for the assessment of blood flow in CAD patients. They are also developing VasoPET, to be used for the detection of vulnerable plaque in CAD patients.
Studies have shown PET imaging to be cost-effective for CAD management. It can result in a 50% reduction in the use of coronary arteriography and CABG, a 30% reduction in CAD management costs, and excellent short-term patient outcomes, compared with conventional SPECT imaging.
For more information, see the company website at www.FluoroPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
However, in spite of huge investments in drugs to fight the disease, it is becoming clear that drugs cannot cure coronary artery disease. Although progress has been made in reducing LDL (sometimes called the “bad” cholesterol, a risk factor for CAD), the fact remains that up to 35% of heart attack patients do not have high blood cholesterol levels, even though most of them have atherosclerosis (hardening of the arteries). In addition, attempts to use drugs to raise the level of HDL (“good” cholesterol) have proven unsuccessful.
The best weapon to use against CAD remains early diagnosis and diagnostic follow-up, using sophisticated technologies such as positron emission tomography (PET) scanning, the best technology for detecting the subtle biological processes associated with CAD and other diseases. And this is exactly the market targeted by FluoroPharma Medical, developers of advanced tracer chemicals needed to make PET effective. FluoroPharma’s two lead products are CardioPET, used for the assessment of myocardial metabolism, and BFPET, used for the assessment of blood flow in CAD patients. They are also developing VasoPET, to be used for the detection of vulnerable plaque in CAD patients.
Studies have shown PET imaging to be cost-effective for CAD management. It can result in a 50% reduction in the use of coronary arteriography and CABG, a 30% reduction in CAD management costs, and excellent short-term patient outcomes, compared with conventional SPECT imaging.
For more information, see the company website at www.FluoroPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Lexicon Pharmaceuticals, Inc. (LXRX) Publishes Results of Two Initial Trials of LX4211
Lexicon Pharmaceuticals is a biopharmaceutical company focused on finding breakthrough disease treatments. The company’s research team, using proprietary knockout gene technology, currently has five drug programs in mid-stage development for diabetes, glaucoma, rheumatoid arthritis, irritable bowel syndrome, and carcinoid syndrome.
The company today announced the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics. The paper will also appear in an upcoming print edition of the publication.
In the 4-week Phase 2a study described in the paper, 36 patients received once-daily oral administration of either a placebo or 150 milligrams or 300 milligrams of LX4211 in a randomized 1:1:1 fashion. Patients receiving LX4211 exhibited rapid and significant improvements relative to the placebo in multiple measures of glycemic control, including hemoglobal A1c, fasting plasma glucose, and oral glucose tolerance.
There were other positive results too. Additionally, serum triglycerides were significantly lower at the end of the 4-week treatment period and trends of meaningful reductions in body weight and blood pressure were observed. Importantly, LX4211 treatment demonstrated a favorable safety profile and was well tolerated in the studies.
Also described the paper was a subsequent clinical study conducted in poorly-controlled patients with type 2 diabetes. It showed that LX4211 treatment elevated levels of two gastrointestinal peptides, GLP-1 and PYY, known to be associated with enhanced metabolic control. It did so through inhibiting both SGLT1 and SGLT2.
For further information about Lexicon Pharmaceuticals, LX4211, and its other drug candidates, please visit the company’s website at www.lexpharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company today announced the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics. The paper will also appear in an upcoming print edition of the publication.
In the 4-week Phase 2a study described in the paper, 36 patients received once-daily oral administration of either a placebo or 150 milligrams or 300 milligrams of LX4211 in a randomized 1:1:1 fashion. Patients receiving LX4211 exhibited rapid and significant improvements relative to the placebo in multiple measures of glycemic control, including hemoglobal A1c, fasting plasma glucose, and oral glucose tolerance.
There were other positive results too. Additionally, serum triglycerides were significantly lower at the end of the 4-week treatment period and trends of meaningful reductions in body weight and blood pressure were observed. Importantly, LX4211 treatment demonstrated a favorable safety profile and was well tolerated in the studies.
Also described the paper was a subsequent clinical study conducted in poorly-controlled patients with type 2 diabetes. It showed that LX4211 treatment elevated levels of two gastrointestinal peptides, GLP-1 and PYY, known to be associated with enhanced metabolic control. It did so through inhibiting both SGLT1 and SGLT2.
For further information about Lexicon Pharmaceuticals, LX4211, and its other drug candidates, please visit the company’s website at www.lexpharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Thursday, June 28, 2012
Peak Resources Ltd. (PKRLY) Boots Visibility and Builds Investor Confidence with Premier OTCQX Listing
Earlier today, Peak Resources announced that its common shares have begun trading on the highest tier of the OTC market, OTCQX. Providing easy access to U.S. investors, this tier is reserved for companies with the highest financial standards. Companies that join OTCQX demonstrate their commitment to providing superior information to investors and maintaining the highest quality standards.
“We are extremely pleased to join the prestigious tier OTCQX,” stated Richard Beazley, Managing Director of Peak Resources. “The superior information and visibility of the OTCQX marketplace will help Peak Resources build investor confidence and expand our shareholder base. As we continue to develop our highly prospective exploration portfolio, trading on the OTCQX will help to broaden Peak Resources investor reach by allowing a large number of U.S. investors to market our shares and by making it easier for U.S. investors to trade our stock.”
Based in Perth, Australia, Peak Resources is focused on the exploration and development of its highly prospective exploration portfolio. The company’s Ngualla Rare Earth Project in southern Tanzania contains a large new high-grade rare earth discovery that ranks as the fifth largest deposit outside of China. Additionally, Peak holds a number of gold exploration projects in the prolific Lake Victoria Gold Fields region of northern Tanzania.
To learn more about Peak Resources and its exploration portfolio, visit www.peakresources.com.au
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We are extremely pleased to join the prestigious tier OTCQX,” stated Richard Beazley, Managing Director of Peak Resources. “The superior information and visibility of the OTCQX marketplace will help Peak Resources build investor confidence and expand our shareholder base. As we continue to develop our highly prospective exploration portfolio, trading on the OTCQX will help to broaden Peak Resources investor reach by allowing a large number of U.S. investors to market our shares and by making it easier for U.S. investors to trade our stock.”
Based in Perth, Australia, Peak Resources is focused on the exploration and development of its highly prospective exploration portfolio. The company’s Ngualla Rare Earth Project in southern Tanzania contains a large new high-grade rare earth discovery that ranks as the fifth largest deposit outside of China. Additionally, Peak holds a number of gold exploration projects in the prolific Lake Victoria Gold Fields region of northern Tanzania.
To learn more about Peak Resources and its exploration portfolio, visit www.peakresources.com.au
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
VistaGen Therapeutics (VSTA) Promotes Efficient Drug Development
The understanding and mastery of human stem cells has grown into a major industry. It is becoming increasingly clear that stem cells play an ongoing and vital role in the human body, and knowing how to work with them could open up a world of disease treatments and preventions.
The advantage of stem cells is in the way they reproduce. When we think of cell reproduction, it’s natural to call up the image of a single cell slowly splitting, dividing itself into two identical copies of the original. But stem cells are different. Although stem cells have the ability to make copies of themselves, they also have the ability to divide asymmetrically. With asymmetric division, the result is both a copy of the original and a progenitor cell that can go on to reproduce and differentiate into specific cell types, such as heart cells or liver cells. The potential for using stem cells to generate new tissues and even entire organs is one of the driving forces behind this rapidly expanding billion dollar industry.
It also turns out that stem cell technology can be used in supporting the development of new drugs. VistaGen in particular has created a unique stem cell based drug testing system that allows drug developers to find out early in development whether a new drug candidate might have heart or liver toxicity issues down the line. It’s a tool that could easily save the drug industry billions of dollars every year as they avoid heading down the wrong path. In addition, drug companies can use this critical information to identify the candidates most likely to succeed, meaning that money is spent more efficiently, and more safe and effective drugs can be developed with given resources.
For additional information, visit the company’s website at www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The advantage of stem cells is in the way they reproduce. When we think of cell reproduction, it’s natural to call up the image of a single cell slowly splitting, dividing itself into two identical copies of the original. But stem cells are different. Although stem cells have the ability to make copies of themselves, they also have the ability to divide asymmetrically. With asymmetric division, the result is both a copy of the original and a progenitor cell that can go on to reproduce and differentiate into specific cell types, such as heart cells or liver cells. The potential for using stem cells to generate new tissues and even entire organs is one of the driving forces behind this rapidly expanding billion dollar industry.
It also turns out that stem cell technology can be used in supporting the development of new drugs. VistaGen in particular has created a unique stem cell based drug testing system that allows drug developers to find out early in development whether a new drug candidate might have heart or liver toxicity issues down the line. It’s a tool that could easily save the drug industry billions of dollars every year as they avoid heading down the wrong path. In addition, drug companies can use this critical information to identify the candidates most likely to succeed, meaning that money is spent more efficiently, and more safe and effective drugs can be developed with given resources.
For additional information, visit the company’s website at www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
BioClinica, Inc. (BIOC) and C.R. Bard Receive Microsoft Life Sciences Innovation Award
BioClinica, a provider of clinical trial management solutions worldwide, announced that, along with C.R. Bard, it has won Microsoft Corporation’s prestigious Life Sciences Innovation Award. The award honors companies that utilize Microsoft solutions in the realization of business and information technology benefits, and it is presented at the Drug Information Association’s (DIA) 48th Annual Meeting in Philadelphia. BioClinica was given the award for its success in revolutionizing medicine development by helping clients usher therapeutic innovations into the market quicker, fight serious ailments, improve healthcare, and enhance people’s quality of life.
“Now more than ever, the life sciences industry is faced with many challenges including cutting costs and bringing new drugs and therapies to market faster,” said Andrea McGonigle, national managing director, Life Sciences, Microsoft Corporation. “We are impressed with how the winners demonstrate sustainable impacts through technology, and are proud that Microsoft’s software plays an important role in enabling these achievements in life sciences.”
Specifically, BioClinica was acknowledged for the “Monitor Visit Report” capability of its OnPoint Clinical Trial Management System, developed for C.R. Bard. The presence of this capability makes it much easier for clinical site monitors to record crucial study information. The synchronization of local Word documents through SharePoint transforms the data into a connected list, which is then transferred and updated within OnPoint CTMS. This automated synchronization gives site monitors the power to complete forms from any location, always benefiting from maximum “local quality” intelligence, and will result in time savings on the magnitude of thousands of hours, while significantly reducing trial costs.
BioClinica and C.R. Bard were chosen for this award by a panel of industry experts from a collection of life sciences corporations in the pharmaceutical, biotechnology, and medical device industries that are creatively applying technology to develop therapeutic innovations.
“We are honored to have C.R. Bard and BioClinica receive this award in recognition of our partnership to bring new innovations to market. The power of being able to run a clinical trial from one’s Microsoft Outlook client is extremely powerful as visit reports, open action items, clinical documents and monitoring visits are available everywhere, anytime. The moment you connect to a network everything is instantly updated, something which no other CTMS or clinical suite of products has the power to do,” said Peter Benton, President, eClinical Division of BioClinica.
For further information, please visit www.bioclinica.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“Now more than ever, the life sciences industry is faced with many challenges including cutting costs and bringing new drugs and therapies to market faster,” said Andrea McGonigle, national managing director, Life Sciences, Microsoft Corporation. “We are impressed with how the winners demonstrate sustainable impacts through technology, and are proud that Microsoft’s software plays an important role in enabling these achievements in life sciences.”
Specifically, BioClinica was acknowledged for the “Monitor Visit Report” capability of its OnPoint Clinical Trial Management System, developed for C.R. Bard. The presence of this capability makes it much easier for clinical site monitors to record crucial study information. The synchronization of local Word documents through SharePoint transforms the data into a connected list, which is then transferred and updated within OnPoint CTMS. This automated synchronization gives site monitors the power to complete forms from any location, always benefiting from maximum “local quality” intelligence, and will result in time savings on the magnitude of thousands of hours, while significantly reducing trial costs.
BioClinica and C.R. Bard were chosen for this award by a panel of industry experts from a collection of life sciences corporations in the pharmaceutical, biotechnology, and medical device industries that are creatively applying technology to develop therapeutic innovations.
“We are honored to have C.R. Bard and BioClinica receive this award in recognition of our partnership to bring new innovations to market. The power of being able to run a clinical trial from one’s Microsoft Outlook client is extremely powerful as visit reports, open action items, clinical documents and monitoring visits are available everywhere, anytime. The moment you connect to a network everything is instantly updated, something which no other CTMS or clinical suite of products has the power to do,” said Peter Benton, President, eClinical Division of BioClinica.
For further information, please visit www.bioclinica.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Duma Energy Corp. (DUMA) is ROI Oriented
Duma Energy is a Houston-based oil and gas exploration and production company that leverages 3D seismic data and other technologies to identify and exploit new and underexplored domestic locations, both on and off-shore. They focus on known domestic reserves, seeking accretive acquisitions of production, reserves, or other oil/gas companies that have the highest potential. The company currently has working operations in Texas, Louisiana, and Illinois.
Duma’s strength is their flexibility. The company invests for strong financial returns, not solely for barrels of oil. They are not bound to any particular geographical locations or operational strategy. Risk is evaluated based upon operation considerations, finances, and industry. They concentrate on only industry standard and time-tested technologies, using as a foundation the extensive experience of their senior leadership. They know what works. They carefully avoid unproven resource plays or other superficially attractive opportunities that depend upon high commodity prices. They prefer to let others risk their money first, and learn from their mistakes.
• Duma is actively producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana.
• They seek aggressive growth through acquisition, existing reserves, and drillable prospects.
• The company has a very strong insider commitment, with CEO and insiders providing more than 75% of the capital invested since inception.
• They are pursuing transformational projects with risk-adjusted, high return on investment (ROI) opportunities.
Duma produced 38,000 barrels of oil equivalent (boe) in fiscal 2011, and has already produced more than 45,000 boe in the first half of fiscal 2012. The company has over $77 million in proven resources, with less than $12 million as booked reserves. Domestic production is projected to exceed 1,000 boe per day by the end of 2012, with 2,500 boe per day by the end of 2013.
For additional information, visit the company’s website at www.DUMA.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Duma’s strength is their flexibility. The company invests for strong financial returns, not solely for barrels of oil. They are not bound to any particular geographical locations or operational strategy. Risk is evaluated based upon operation considerations, finances, and industry. They concentrate on only industry standard and time-tested technologies, using as a foundation the extensive experience of their senior leadership. They know what works. They carefully avoid unproven resource plays or other superficially attractive opportunities that depend upon high commodity prices. They prefer to let others risk their money first, and learn from their mistakes.
• Duma is actively producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana.
• They seek aggressive growth through acquisition, existing reserves, and drillable prospects.
• The company has a very strong insider commitment, with CEO and insiders providing more than 75% of the capital invested since inception.
• They are pursuing transformational projects with risk-adjusted, high return on investment (ROI) opportunities.
Duma produced 38,000 barrels of oil equivalent (boe) in fiscal 2011, and has already produced more than 45,000 boe in the first half of fiscal 2012. The company has over $77 million in proven resources, with less than $12 million as booked reserves. Domestic production is projected to exceed 1,000 boe per day by the end of 2012, with 2,500 boe per day by the end of 2013.
For additional information, visit the company’s website at www.DUMA.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
GlobalWise Investments, Inc. (GWIV) Hits Home Run with Sycle.net
In a recent interview that Hearing Review had with Sycle.net, a GlobalWise channel sales partner, it was clear that Sycle.net was especially enthusiastic about eDocs, the just launched cloud-based document management system developed in partnership with GlobalWise subsidiary Intellinetics.
Sycle.net is the largest provider of cloud-based ERP (Enterprise Resource Planning) software systems specifically designed for the hearing care industry. They support over 65% of the audiology clinics in the U.S., and are growing by approximately 50 clinics every month. The company spent many months researching to identify the right ECM (Enterprise Content Management) software provider to help Sycle’s customers get a handle on all the patient documents naturally associated with health care environments. As their CEO, Ridge Sampson, stated: “Nothing is more important than our reputation with our audiology clients”. Their final choice was GlobaWise, and their Intellinetics Intellivue software platform. There were a number of factors involved in the choice, but one was the ability to easily and seamlessly integrate the Intellivue software platform into pre-existing software systems such as Sycle.net’s.
eDocs enhances the ability of authorized Sycle.net clients to access patient documents wherever there is Internet access. For example, eDocs allows an individual user to leave work, go home or travel, and then later use their own computer or other point of access to have all updated patient documents in front of them. It’s not only tremendously flexible, it’s a big step in freeing up storage space, making the entire business environment easier to manage. One of the early users of the system spoke of the major efficiencies gained by accessing clinical records using their fleet of iPads, and talked about being able to process over 14,000 documents in only 20 business days.
All of this represents a big win for GlobalWise, both now and in the future. Sycle.net serves over 6,000 audiology clinics and 18,000 individual users, providing an unbeatable opportunity for the company to rapidly expand the installed client base.
To see the complete interview, visit http://www.hearingreview.com/issues/articles/HPR_2012-05_04.asp
For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Sycle.net is the largest provider of cloud-based ERP (Enterprise Resource Planning) software systems specifically designed for the hearing care industry. They support over 65% of the audiology clinics in the U.S., and are growing by approximately 50 clinics every month. The company spent many months researching to identify the right ECM (Enterprise Content Management) software provider to help Sycle’s customers get a handle on all the patient documents naturally associated with health care environments. As their CEO, Ridge Sampson, stated: “Nothing is more important than our reputation with our audiology clients”. Their final choice was GlobaWise, and their Intellinetics Intellivue software platform. There were a number of factors involved in the choice, but one was the ability to easily and seamlessly integrate the Intellivue software platform into pre-existing software systems such as Sycle.net’s.
eDocs enhances the ability of authorized Sycle.net clients to access patient documents wherever there is Internet access. For example, eDocs allows an individual user to leave work, go home or travel, and then later use their own computer or other point of access to have all updated patient documents in front of them. It’s not only tremendously flexible, it’s a big step in freeing up storage space, making the entire business environment easier to manage. One of the early users of the system spoke of the major efficiencies gained by accessing clinical records using their fleet of iPads, and talked about being able to process over 14,000 documents in only 20 business days.
All of this represents a big win for GlobalWise, both now and in the future. Sycle.net serves over 6,000 audiology clinics and 18,000 individual users, providing an unbeatable opportunity for the company to rapidly expand the installed client base.
To see the complete interview, visit http://www.hearingreview.com/issues/articles/HPR_2012-05_04.asp
For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
BioDelivery Sciences International, Inc. (BDSI) Demonstrates Positive Results in Recent Study
BioDelivery Sciences International recently completed an FDA recommended trial as part of the New Drug Application (NDA) to examine the effects of multiple BEMA Buprenorphine/Naloxone (BNX) films administered concurrently. Results of the pharmacokinetic study were positive, indicating that the NDA is on track for submission in early 2013. BDSI expects to have key data from the study in the third quarter of 2012, and the final clinical requirement for an open label study will be initiated at this time.
The intention of the study was to examine dose proportionality ahead of the forthcoming pharmacokinetic study. The results confirmed that the buprenorphine pharmacokinetics were nearly identical following multiple BNX films applied at one time compared to an equivalent dose administered as a single film. Additionally, a linear relationship was found in buprenorphine pharmacokinetics across the dose range of BNX administered, meaning that as doses of BNX increased, there was a corresponding increase in the amount of buprenorphine in the plasma. The study also demonstrated that the exposure of naloxone is similar to the reference standard, Suboxone, which provides additional confidence that the doses selected for BDSI’s upcoming pivotal pharmacokinetic study for BNX will produce similar buprenorphine pharmacokinetics as the reference standard. This pivotal pharmacokinetic study is a critical component of the NDA.
“We are pleased to have again demonstrated the ability of our BEMA drug delivery technology to provide solid dose proportionality,” said Dr. Andrew Finn, Executive Vice President of Product Development. “The outcome of this study not only satisfies the FDA’s request for a multiple film evaluation, but it also enhances the probability of success for BNX in our upcoming pivotal pharmacokinetic study versus Suboxone.”
Nearly 2 million people in the US are dependent on prescription opioids according to the 2010 National Survey on Drug Use and Health, conducted by the U.S. Department of Health and Human Services. Suboxone was approved in 2002 and currently generates annual sales of more than $1.2 billion, growing over 20% in 2011 according to data from Wolters Kluwer, and has been shown to be a highly effective treatment option. BDSI believes that BNX, which uses BDSI’s proprietary BEMA delivery technology, has the potential to offer advantages over Suboxone and could capture significant market share.
BioDelivery Sciences International, headquartered in Raleigh, NC, is a specialty pharmaceutical company that leverages patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI focuses on developing products that meet unmet patient needs in the areas of pain management and oncology supportive care.
BDSI’s pain franchise currently consists of two products utilizing the patented BEMA technology:
• ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer. The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).
• BEMA Buprenorphine is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation with naloxone for the treatment of opioids.
For more information, visit www.bdsi.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The intention of the study was to examine dose proportionality ahead of the forthcoming pharmacokinetic study. The results confirmed that the buprenorphine pharmacokinetics were nearly identical following multiple BNX films applied at one time compared to an equivalent dose administered as a single film. Additionally, a linear relationship was found in buprenorphine pharmacokinetics across the dose range of BNX administered, meaning that as doses of BNX increased, there was a corresponding increase in the amount of buprenorphine in the plasma. The study also demonstrated that the exposure of naloxone is similar to the reference standard, Suboxone, which provides additional confidence that the doses selected for BDSI’s upcoming pivotal pharmacokinetic study for BNX will produce similar buprenorphine pharmacokinetics as the reference standard. This pivotal pharmacokinetic study is a critical component of the NDA.
“We are pleased to have again demonstrated the ability of our BEMA drug delivery technology to provide solid dose proportionality,” said Dr. Andrew Finn, Executive Vice President of Product Development. “The outcome of this study not only satisfies the FDA’s request for a multiple film evaluation, but it also enhances the probability of success for BNX in our upcoming pivotal pharmacokinetic study versus Suboxone.”
Nearly 2 million people in the US are dependent on prescription opioids according to the 2010 National Survey on Drug Use and Health, conducted by the U.S. Department of Health and Human Services. Suboxone was approved in 2002 and currently generates annual sales of more than $1.2 billion, growing over 20% in 2011 according to data from Wolters Kluwer, and has been shown to be a highly effective treatment option. BDSI believes that BNX, which uses BDSI’s proprietary BEMA delivery technology, has the potential to offer advantages over Suboxone and could capture significant market share.
BioDelivery Sciences International, headquartered in Raleigh, NC, is a specialty pharmaceutical company that leverages patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI focuses on developing products that meet unmet patient needs in the areas of pain management and oncology supportive care.
BDSI’s pain franchise currently consists of two products utilizing the patented BEMA technology:
• ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer. The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).
• BEMA Buprenorphine is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation with naloxone for the treatment of opioids.
For more information, visit www.bdsi.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
ERF Wireless, Inc. (ERFB) Introduces a GPS-Based e911 Solution for Oil and Gas Clients to Safeguard Remote Drilling Operations
ERF Wireless, through its subsidiaries (Energy Broadband Inc., ERF Enterprise Network Services, ERF Wireless Bundled Services, ERF Wireless Messaging Services, and ERF Network Operations) has developed an impressive array of wireless broadband technologies/service offerings, including the biggest terrestrial wireless network in the country for handling the needs of the oil and gas exploration sector, announced a specialized, GPS-based e911 system for their wireless network services today via subsidiary Energy Broadband.
With a majority of revenue streaming in directly from providing mission critical, terrestrial wireless broadband communications to domestic oil and gas rigs operating in remote areas, this awesome new feature brings a whole new meaning to the phrase that is typically used to describe the company’s already widely acclaimed services (including VoIP), “best of class.”
It cannot be stressed how important emergency 911 is for these kinds of remote operations. There are often no marked roads or at best a newly cut work road; typically there isn’t even a physical address, making emergency relief via standard 911 unavailable (even if there is a physical address it probably won’t be located on any available map). But now that this breakthrough technological advancement is being rolled out, we have real-time GPS coordination that is extensible to a variety of mapping methods, making it very simple to provide (often potentially life-saving) support for protecting rig-site workers.
Talk about a huge draw for oil and gas developers, this e911 system that marries the VoIP telephones already deployed on the work site to dispatch-ready GPS capabilities closes the loop between accident/injury and care, one of the biggest concerns for any developer doing business at a remote (often dangerous or difficult) location. The ability to provide this umbrella of protection for workers, where it was previously not available or possible, will draw in even more of the sector to EFRB, helping to cement the company’s already strong market position.
CEO of EFRB, Dr. Dean Cubley, sighted this latest development as a clear indication to oil and gas developers that the company remains committed to providing the premier communication services envelope to their rapidly growing customer base.
One can easily imagine site foremen breathing a sigh of relief, knowing that when and if the unthinkable happens, emergency services are just a phone call away and the personnel can get right to them with any simple GPS-enabled device using those coordinates. The name ERF Wireless should spread ever more rapidly throughout the sector as a result of this advancement. The broader enterprise, commercial, and residential markets served both domestically and internationally by the company and its subsidiaries are well aware of this tireless drive for innovation by ERFB.
ERFB management has 40 years of work in wireless broadband, as well as network integration, triple-play FTTH (fiber to the home), IPTV, and sophisticated content delivery methods. Employing bleeding-edge technology and the company’s proprietary CryptoVue® Network Security Appliance, ERFB has already made big waves in the banking industry (over 100 locations across three states), where the competitive edge the company is able to assert has crushed expensive T1 telephony solutions. Initiatives like the recent expansion of the product portfolio to include luxury resort community-targeted triple-play Voice, Video, and Internet system, combined with a rich menu of wireless broadband services, has enabled ERFB to create a dynamic, appealing turnkey solution that can be rolled out to global markets with ease.
Yes, the already impressive wireless network coverage available to customers in hydrocarbon rich development areas like Texas, New Mexico, Oklahoma, and Louisiana has just gotten much safer and much better, thanks to ERFB.
For more information on the GPS-based e911 service, or to learn more about ERF Wireless, Inc., please visit the company’s websites at: www.ERFWireless.com and www.ERFWireless.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
With a majority of revenue streaming in directly from providing mission critical, terrestrial wireless broadband communications to domestic oil and gas rigs operating in remote areas, this awesome new feature brings a whole new meaning to the phrase that is typically used to describe the company’s already widely acclaimed services (including VoIP), “best of class.”
It cannot be stressed how important emergency 911 is for these kinds of remote operations. There are often no marked roads or at best a newly cut work road; typically there isn’t even a physical address, making emergency relief via standard 911 unavailable (even if there is a physical address it probably won’t be located on any available map). But now that this breakthrough technological advancement is being rolled out, we have real-time GPS coordination that is extensible to a variety of mapping methods, making it very simple to provide (often potentially life-saving) support for protecting rig-site workers.
Talk about a huge draw for oil and gas developers, this e911 system that marries the VoIP telephones already deployed on the work site to dispatch-ready GPS capabilities closes the loop between accident/injury and care, one of the biggest concerns for any developer doing business at a remote (often dangerous or difficult) location. The ability to provide this umbrella of protection for workers, where it was previously not available or possible, will draw in even more of the sector to EFRB, helping to cement the company’s already strong market position.
CEO of EFRB, Dr. Dean Cubley, sighted this latest development as a clear indication to oil and gas developers that the company remains committed to providing the premier communication services envelope to their rapidly growing customer base.
One can easily imagine site foremen breathing a sigh of relief, knowing that when and if the unthinkable happens, emergency services are just a phone call away and the personnel can get right to them with any simple GPS-enabled device using those coordinates. The name ERF Wireless should spread ever more rapidly throughout the sector as a result of this advancement. The broader enterprise, commercial, and residential markets served both domestically and internationally by the company and its subsidiaries are well aware of this tireless drive for innovation by ERFB.
ERFB management has 40 years of work in wireless broadband, as well as network integration, triple-play FTTH (fiber to the home), IPTV, and sophisticated content delivery methods. Employing bleeding-edge technology and the company’s proprietary CryptoVue® Network Security Appliance, ERFB has already made big waves in the banking industry (over 100 locations across three states), where the competitive edge the company is able to assert has crushed expensive T1 telephony solutions. Initiatives like the recent expansion of the product portfolio to include luxury resort community-targeted triple-play Voice, Video, and Internet system, combined with a rich menu of wireless broadband services, has enabled ERFB to create a dynamic, appealing turnkey solution that can be rolled out to global markets with ease.
Yes, the already impressive wireless network coverage available to customers in hydrocarbon rich development areas like Texas, New Mexico, Oklahoma, and Louisiana has just gotten much safer and much better, thanks to ERFB.
For more information on the GPS-based e911 service, or to learn more about ERF Wireless, Inc., please visit the company’s websites at: www.ERFWireless.com and www.ERFWireless.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, June 27, 2012
Cornerstone Therapeutics, Inc. (CRTX) Acquires EKR Therapeutics
Cornerstone Therapeutics today announced the company has finalized the acquisition of privately-held EKR Therapeutics, which will be a wholly owned subsidiary of Cornerstone Therapeutics. The acquisition is expected to be accretive in Q3 2012 on a non-GAAP earnings per share (EPS) basis, with immediate revenue potential from the marketing of the medicine CARDENE® I.V.
Headquartered in Cary, NC, Cornerstone Therapeutics is a specialty pharmaceutical company focused on commercializing products for the hospital, niche respiratory, and related specialty markets.
As part of the acquisition, Cornerstone Therapeutics assumes responsibility(s) for the following medicines:
• CARDENE® I.V. (nicardipine hydrochloride): Cornerstone Therapeutics will immediately assume responsibility for marketing and promotion of CARDENE® I.V., a medicine indicated for the short-term treatment of hypertension as an alternative to oral therapy treatments.
• RETAVASE® (Reteplase): Cornerstone Therapeutics is targeting FDA approval of a new active ingredient supplier and plans to relaunch RETAVASE to the market in 2013. RETAVASE is a medicine indicated for use in the management, improvement of ventricular function, and reduction of incidences of congestive heart failures related to the condition of acute myocardial infarction (AMI) in adults.
“We believe this transaction delivers on our promise to transform Cornerstone into a leading specialty pharmaceutical company that provides hospital and related specialty market products,” said Craig A. Collard, Cornerstone’s Chief Executive Officer. “We expect that the combination of Cornerstone and EKR will generate synergies, while the addition of the EKR sales force will significantly expand our reach in the U.S. hospital market. With the launch of CRTX 080 (lixivaptan) and the relaunch of RETAVASE in 2013, our sales force will be actively promoting four products within the hospital channel. From a revenue growth perspective, we believe that annualized sales from CARDENE I.V. could exceed $50 million.”
Collard added, “Lixivaptan is under review by the FDA for the treatment of hyponatremia, which is a common condition in patients with heart failure. With the acquisition of EKR and specifically, CARDENE I.V., we have the opportunity to strengthen our existing relationships within the cardiology community as we prepare for the approval and launch of lixivaptan.”
Terms of the acquisition agreement include:
• An initial cash payment of approximately $125 million.
• Additional payments contingent upon the achievement of certain milestones related to regulatory approval of a new active ingredient supplier for RETAVASE and sales of RETAVASE during approximately the first three years following commercial relaunch.
• A credit agreement with Chiesi Farmaceutici, S.p.A., its largest shareholder, in which Chiesi is providing a five-year Term Loan A of $60 million and a five-year Term Loan B of $30 million. The Term Loan B may be converted into common stock of Cornerstone at $7.098 per share at Chiesi’s option at any time during the first 24 months following the closing of the credit arrangement.
“We believe the terms of the credit arrangement with Chiesi are favorable to Cornerstone when compared to financing alternatives that may be available to us in the public markets,” said Vincent T. Morgus, Cornerstone’s Chief Financial Officer. “More importantly, we believe our ability to access Chiesi as a financing source will continue to help us capitalize on new potential growth opportunities.”
For more information, visit www.crtx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Headquartered in Cary, NC, Cornerstone Therapeutics is a specialty pharmaceutical company focused on commercializing products for the hospital, niche respiratory, and related specialty markets.
As part of the acquisition, Cornerstone Therapeutics assumes responsibility(s) for the following medicines:
• CARDENE® I.V. (nicardipine hydrochloride): Cornerstone Therapeutics will immediately assume responsibility for marketing and promotion of CARDENE® I.V., a medicine indicated for the short-term treatment of hypertension as an alternative to oral therapy treatments.
• RETAVASE® (Reteplase): Cornerstone Therapeutics is targeting FDA approval of a new active ingredient supplier and plans to relaunch RETAVASE to the market in 2013. RETAVASE is a medicine indicated for use in the management, improvement of ventricular function, and reduction of incidences of congestive heart failures related to the condition of acute myocardial infarction (AMI) in adults.
“We believe this transaction delivers on our promise to transform Cornerstone into a leading specialty pharmaceutical company that provides hospital and related specialty market products,” said Craig A. Collard, Cornerstone’s Chief Executive Officer. “We expect that the combination of Cornerstone and EKR will generate synergies, while the addition of the EKR sales force will significantly expand our reach in the U.S. hospital market. With the launch of CRTX 080 (lixivaptan) and the relaunch of RETAVASE in 2013, our sales force will be actively promoting four products within the hospital channel. From a revenue growth perspective, we believe that annualized sales from CARDENE I.V. could exceed $50 million.”
Collard added, “Lixivaptan is under review by the FDA for the treatment of hyponatremia, which is a common condition in patients with heart failure. With the acquisition of EKR and specifically, CARDENE I.V., we have the opportunity to strengthen our existing relationships within the cardiology community as we prepare for the approval and launch of lixivaptan.”
Terms of the acquisition agreement include:
• An initial cash payment of approximately $125 million.
• Additional payments contingent upon the achievement of certain milestones related to regulatory approval of a new active ingredient supplier for RETAVASE and sales of RETAVASE during approximately the first three years following commercial relaunch.
• A credit agreement with Chiesi Farmaceutici, S.p.A., its largest shareholder, in which Chiesi is providing a five-year Term Loan A of $60 million and a five-year Term Loan B of $30 million. The Term Loan B may be converted into common stock of Cornerstone at $7.098 per share at Chiesi’s option at any time during the first 24 months following the closing of the credit arrangement.
“We believe the terms of the credit arrangement with Chiesi are favorable to Cornerstone when compared to financing alternatives that may be available to us in the public markets,” said Vincent T. Morgus, Cornerstone’s Chief Financial Officer. “More importantly, we believe our ability to access Chiesi as a financing source will continue to help us capitalize on new potential growth opportunities.”
For more information, visit www.crtx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
JWC Acquisition Corp. (JWCAU) and The Tile Shop to Form Tile Shop Holdings Venture
JWC Acquisition Corp. and The Tile Shop, LLC, a specialty retailer of manufactured and natural stone tiles and related accessories, today announced their agreement to combine business under a new holding company, Tile Shop Holdings Inc., which intends to apply for listing on the Nasdaq Stock Market under the symbol “TTS” upon the closing of the business combination.
The Tile Shop currently operates 61 specialty retail stores in 20 states, with eight of the stores opened in 2012. Through its merger with JWC, The Tile Shop says it is positioned to leverage greater access to capital to further execute on its profitable long-term growth strategy. The company intends to open an additional five stores in the remainder of 2012 and expects to open no less than 15 stores in 2013.
“This transaction marks the next step in The Tile Shop’s evolution into the leading North American specialty retailer of tile. As a public company, we not only will continue with our self-funded store growth across the country, but also be better positioned to take advantage of additional resources to accelerate our growth as the demand for our products increases,” Bob Rucker, CEO and founder of The Tile Shop, stated in the press release. “The agreement with JWC Acquisition Corp. supports our ability to pursue attractive growth opportunities in both current and new markets. As we continue to expand and gain market share in this highly-fragmented market, we should be able to increase both sales and cash flow, which will enhance our profitability over time.”
The Tile Shop has thus far demonstrated its ability to mature, as represented by store expansion and revenue growth. The company reported net sales of $152.7 million for the year ended December 31, 2011, an increase of 12.8 percent vs. $135.3 million in 2010. Adjusted EBITDA of $42.6 million represents an increase of 10.7 percent vs. $38.5 million in 2010.
From 2007 through 2011, The Tile Shop has achieved net sales and Adjusted EBITDA increases at compounded annual growth rates of 8.2 percent and 13.3 percent, respectively, driven by new retail locations and increases in same store sales.
The Tile Shop’s net sales for the quarter ended March 31, 2012, increased 21.1 percent to $45.9 million compared to $37.9 million in the first quarter of 2011.
For more information visit www.tileshop.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The Tile Shop currently operates 61 specialty retail stores in 20 states, with eight of the stores opened in 2012. Through its merger with JWC, The Tile Shop says it is positioned to leverage greater access to capital to further execute on its profitable long-term growth strategy. The company intends to open an additional five stores in the remainder of 2012 and expects to open no less than 15 stores in 2013.
“This transaction marks the next step in The Tile Shop’s evolution into the leading North American specialty retailer of tile. As a public company, we not only will continue with our self-funded store growth across the country, but also be better positioned to take advantage of additional resources to accelerate our growth as the demand for our products increases,” Bob Rucker, CEO and founder of The Tile Shop, stated in the press release. “The agreement with JWC Acquisition Corp. supports our ability to pursue attractive growth opportunities in both current and new markets. As we continue to expand and gain market share in this highly-fragmented market, we should be able to increase both sales and cash flow, which will enhance our profitability over time.”
The Tile Shop has thus far demonstrated its ability to mature, as represented by store expansion and revenue growth. The company reported net sales of $152.7 million for the year ended December 31, 2011, an increase of 12.8 percent vs. $135.3 million in 2010. Adjusted EBITDA of $42.6 million represents an increase of 10.7 percent vs. $38.5 million in 2010.
From 2007 through 2011, The Tile Shop has achieved net sales and Adjusted EBITDA increases at compounded annual growth rates of 8.2 percent and 13.3 percent, respectively, driven by new retail locations and increases in same store sales.
The Tile Shop’s net sales for the quarter ended March 31, 2012, increased 21.1 percent to $45.9 million compared to $37.9 million in the first quarter of 2011.
For more information visit www.tileshop.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
NCI, Inc. (NCIT) Awarded $6.4 Million Task Order for Services to U.S. Army
NCI announced yesterday that it has been awarded a competitive task order valued at $6.4 million to provide modeling, simulation, and network operations security center (NOSC) engineering support for the United States Army’s Signal Center of Excellence, Capabilities Development Integration Directorate, Experimentation Division located at Fort Gordon, GA. The period of performance begins July 1st and includes a base year and two option years.
According to the task order, NCI will develop modeling and simulation tools, information-dissemination management tools, data, products, analysis methods, and deliverables for the Government to use in support of the Army’s current and future communications experimentation and analytical requirements.
The task also includes maintaining the NOSC for the Battle Lab Collaborative Simulation Environment (BLCSE), which supports all the Training and Doctrine Command’s distributed experimentation events in a classified environment. BLCSE support includes day-to-day operations for approximately 24 distributed sites in the areas of system administration, collaboration tools, network design, network and data implementation, and information assurance requirements.
Brian J. Clark, NCI’s president, remarked, “NCI is very pleased to broaden our relationship with the Army through services we will provide to the U.S. Army’s Signal Center of Excellence at Fort Gordon. This award not only represents new business for NCI, but also a strategic entrée into a key new location. We look forward to supporting the mission of the Capabilities Development Integration Directorate, Experimentation Division.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
According to the task order, NCI will develop modeling and simulation tools, information-dissemination management tools, data, products, analysis methods, and deliverables for the Government to use in support of the Army’s current and future communications experimentation and analytical requirements.
The task also includes maintaining the NOSC for the Battle Lab Collaborative Simulation Environment (BLCSE), which supports all the Training and Doctrine Command’s distributed experimentation events in a classified environment. BLCSE support includes day-to-day operations for approximately 24 distributed sites in the areas of system administration, collaboration tools, network design, network and data implementation, and information assurance requirements.
Brian J. Clark, NCI’s president, remarked, “NCI is very pleased to broaden our relationship with the Army through services we will provide to the U.S. Army’s Signal Center of Excellence at Fort Gordon. This award not only represents new business for NCI, but also a strategic entrée into a key new location. We look forward to supporting the mission of the Capabilities Development Integration Directorate, Experimentation Division.”
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Meru Networks, Inc. (MERU) Announces Improvements to Cutting-Edge BYOD and Guest Access Wi-Fi Solution
Meru Networks, a leader in virtualized 802.11 enterprise wireless networks, announced that it has made its Identity Manager product available. Identity Manager is the industry’s original integrated Bring-Your-Own-Device (BYOD) provisioning and guest access solution with the capability of using a Property Management System (PMS).
Identity Manager is able to streamline secure guest access and BYOD provisioning for nearly every operating and network in use today. This simplification drastically decreases IT workload while delivering an easy on-boarding experience for users. The integrated software platform, deployed at over 2,500 customers, is comprised of two modules, the first of which is known as Smart Connect. Smart Connect enables automated BYOD client provisioning. The second module is the Guest Connect network access solution, which integrates perfectly with property management systems and payment gateways. This integration simplifies administrative tasks and billing for guest Internet access, allowing customers to effortlessly accept credit card payments from their guests.
Using Meru Identity Manager, enterprises can easily and effectively serve the thousands of Wi-Fi devices and applications that are used within their wireless environment, delivering smooth network access in accordance with corporate IT policies.
News Facts:
• Meru Identity Manager now has integrated Property Management System (PMS) functionality that enables businesses, including hotels and convention centers, to automate service charges for Wi-Fi or Internet access services, and automatically post service charges to over 80 different popular industry billing entities.
• Meru Identity Manager’s vendor agnostic architecture enables it to provision services over wired or wireless networks.
• Clients supported by Meru Identity Manager include Apple iOS (iPhone and iPad), Apple Mac OS X, Google Android, Linux and Microsoft Windows (XP, Vista and 7).
• Meru Identity Manager is designed to reduce IT workload by automating the device and user on-boarding process without jeopardizing network security.
• Enterprise-strength authentication and encryption protect the network and sensitive data, while role-based and policy-based provisioning gives IT departments control over whom and what devices get access.
• Identity Manager is designed to deliver the industry’s most complete and comprehensive activity monitoring/reporting for guest users and devices, which is critical for ensuring appropriate use to protect company networks.
• Identity Manager technology is currently deployed in over 2,500 customer accounts worldwide, including many Fortune 500 companies, higher education institutions, large hotel chains, major league sports stadiums, and global convention centers.
• Identity Manager is available in a VMware ready format for customers who have chosen a virtualized application platform strategy.
For further information, please visit www.merunetworks.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Identity Manager is able to streamline secure guest access and BYOD provisioning for nearly every operating and network in use today. This simplification drastically decreases IT workload while delivering an easy on-boarding experience for users. The integrated software platform, deployed at over 2,500 customers, is comprised of two modules, the first of which is known as Smart Connect. Smart Connect enables automated BYOD client provisioning. The second module is the Guest Connect network access solution, which integrates perfectly with property management systems and payment gateways. This integration simplifies administrative tasks and billing for guest Internet access, allowing customers to effortlessly accept credit card payments from their guests.
Using Meru Identity Manager, enterprises can easily and effectively serve the thousands of Wi-Fi devices and applications that are used within their wireless environment, delivering smooth network access in accordance with corporate IT policies.
News Facts:
• Meru Identity Manager now has integrated Property Management System (PMS) functionality that enables businesses, including hotels and convention centers, to automate service charges for Wi-Fi or Internet access services, and automatically post service charges to over 80 different popular industry billing entities.
• Meru Identity Manager’s vendor agnostic architecture enables it to provision services over wired or wireless networks.
• Clients supported by Meru Identity Manager include Apple iOS (iPhone and iPad), Apple Mac OS X, Google Android, Linux and Microsoft Windows (XP, Vista and 7).
• Meru Identity Manager is designed to reduce IT workload by automating the device and user on-boarding process without jeopardizing network security.
• Enterprise-strength authentication and encryption protect the network and sensitive data, while role-based and policy-based provisioning gives IT departments control over whom and what devices get access.
• Identity Manager is designed to deliver the industry’s most complete and comprehensive activity monitoring/reporting for guest users and devices, which is critical for ensuring appropriate use to protect company networks.
• Identity Manager technology is currently deployed in over 2,500 customer accounts worldwide, including many Fortune 500 companies, higher education institutions, large hotel chains, major league sports stadiums, and global convention centers.
• Identity Manager is available in a VMware ready format for customers who have chosen a virtualized application platform strategy.
For further information, please visit www.merunetworks.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
GlobalWise Investments, Inc. (GWIV) Continues to Drive International Expansion with Channel Partner Strategy
GlobalWise Investments, Inc. and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today provided investors with an update on the company’s progress to date and near term intentions to expand into international markets.
For nearly two decades, Intellinetics has focused primarily on domestic United States markets, selling ECM software services through a traditional, direct sales force. This strategy has served Intellinetics well, but the original father-son management team of Matthew and Michael Chretien saw the opportunity to expand the business by hiring international executive William J. “BJ” Santiago. Recruited from Lexmark, Mr. Santiago was brought on to lead the new cloud-based ECM software enterprise and expand the company’s distribution through a one-to-many strategy utilizing Channel Partners who already have a tested and proven model to sell hardware or software related services.
Eight new Channel Partners have been brought on in just the past seven months to continue software sales expansion in the United States, as well as pursue new opportunities internationally. This Channel Partner strategy has shown it is possible to distribute ECM software services in every industry. By utilizing distribution partners who already have an extensive sales force and customer base, GlobalWise is able to focus on being a software company while the Partners emphasize on client sales and on-going support.
Recently, the company announced an agreement with SOIN Integrales (www.soin.co.cr), headquartered in Costa Rica, who dominates the Latin America market selling high-end ERP solutions from companies like Oracle, SAP, and Sybase. Historically, SOIN did not have an ECM (Enterprise Content Management) practice within their software product offerings. However, similar to the US, Latin America is rapidly adopting digital management of document and records for compliance and privacy regulation and historically did not have a cost effective ECM solution.
Today, through the Intellinetics On-demand Solution Store™ templates, SOIN can capitalize on this untapped small to medium sized client base through an exclusive agreement with Intellinetics. Over the past several months, the companies have worked closely together to translate the Intellivue™ software and related product collateral into Spanish and are currently marketing the software services. The initial Intellivue™ solution and product launch has begun in Mexico, Costa Rica, Panama, El Salvador, and Nicaragua.
Additionally, the Intellinetics agreement with MWAi will begin the company’s first foray into English speaking countries in Europe, with expansion expected to begin in the third quarter of 2012. Since Intellinetics has invested heavily in their template based best practice ECM solutions for a variety of industries, the current software will need very little upgrading aside from potential cultural differences. Perhaps even more exciting for Intellinetics and MWAi is the on-going efforts to convert the Intellivue™ cloud-based ECM software into a double-byte character set (DBCS), a software language typical for Japanese, Korean and Chinese translations. By employing DBCS, the Intellinetics software suite will be ready for clients in the Asia-Pacific Rim later this year.
“GlobalWise is positioning itself for record-breaking growth for the balance of 2012 and 2013,” proclaimed William. J. “BJ” Santiago, CEO of GlobalWise. “We have and will continue to recruit many strategic Partners to help us access more industries and markets. I expect we will have additional announcements in the near future regarding further domestic and international growth.”
“The great news with a cloud-based service delivery model, now available in both English and Spanish and soon for the Asian market, is the multitudes of ways to get our software into the hands of clients,” added Mr. Santiago. “Whether it’s integrating the ECM capabilities into an existing CRM or ERP system, implementation with multi-function printers or sold as a stand-alone solution, our software is dynamic enough to sit alongside almost any other architecture. The cloud delivery model provides a lower cost delivery approach without major capital expenditures that is perfect in the emerging ECM markets that previously did not have a cost effective solution.”
For more information on the company, visit www.GlobalWiseInvestments.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
For nearly two decades, Intellinetics has focused primarily on domestic United States markets, selling ECM software services through a traditional, direct sales force. This strategy has served Intellinetics well, but the original father-son management team of Matthew and Michael Chretien saw the opportunity to expand the business by hiring international executive William J. “BJ” Santiago. Recruited from Lexmark, Mr. Santiago was brought on to lead the new cloud-based ECM software enterprise and expand the company’s distribution through a one-to-many strategy utilizing Channel Partners who already have a tested and proven model to sell hardware or software related services.
Eight new Channel Partners have been brought on in just the past seven months to continue software sales expansion in the United States, as well as pursue new opportunities internationally. This Channel Partner strategy has shown it is possible to distribute ECM software services in every industry. By utilizing distribution partners who already have an extensive sales force and customer base, GlobalWise is able to focus on being a software company while the Partners emphasize on client sales and on-going support.
Recently, the company announced an agreement with SOIN Integrales (www.soin.co.cr), headquartered in Costa Rica, who dominates the Latin America market selling high-end ERP solutions from companies like Oracle, SAP, and Sybase. Historically, SOIN did not have an ECM (Enterprise Content Management) practice within their software product offerings. However, similar to the US, Latin America is rapidly adopting digital management of document and records for compliance and privacy regulation and historically did not have a cost effective ECM solution.
Today, through the Intellinetics On-demand Solution Store™ templates, SOIN can capitalize on this untapped small to medium sized client base through an exclusive agreement with Intellinetics. Over the past several months, the companies have worked closely together to translate the Intellivue™ software and related product collateral into Spanish and are currently marketing the software services. The initial Intellivue™ solution and product launch has begun in Mexico, Costa Rica, Panama, El Salvador, and Nicaragua.
Additionally, the Intellinetics agreement with MWAi will begin the company’s first foray into English speaking countries in Europe, with expansion expected to begin in the third quarter of 2012. Since Intellinetics has invested heavily in their template based best practice ECM solutions for a variety of industries, the current software will need very little upgrading aside from potential cultural differences. Perhaps even more exciting for Intellinetics and MWAi is the on-going efforts to convert the Intellivue™ cloud-based ECM software into a double-byte character set (DBCS), a software language typical for Japanese, Korean and Chinese translations. By employing DBCS, the Intellinetics software suite will be ready for clients in the Asia-Pacific Rim later this year.
“GlobalWise is positioning itself for record-breaking growth for the balance of 2012 and 2013,” proclaimed William. J. “BJ” Santiago, CEO of GlobalWise. “We have and will continue to recruit many strategic Partners to help us access more industries and markets. I expect we will have additional announcements in the near future regarding further domestic and international growth.”
“The great news with a cloud-based service delivery model, now available in both English and Spanish and soon for the Asian market, is the multitudes of ways to get our software into the hands of clients,” added Mr. Santiago. “Whether it’s integrating the ECM capabilities into an existing CRM or ERP system, implementation with multi-function printers or sold as a stand-alone solution, our software is dynamic enough to sit alongside almost any other architecture. The cloud delivery model provides a lower cost delivery approach without major capital expenditures that is perfect in the emerging ECM markets that previously did not have a cost effective solution.”
For more information on the company, visit www.GlobalWiseInvestments.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Qualcomm, Inc. (QCOM) Brings Cloud-Based Image Recognition Feature Set to Their Vuforia™ Augmented Reality Platform
Qualcomm, the widely-known, global 3G/next-gen mobile tech juggernaut, in a press release issued today, revealed that the company’s ingenious augmented reality (AR) platform Vuforia™, will bring powerful, new cloud-based image recognition possibilities to the mobile shopping experience.
By bringing together cloud-based image recognition and the Vuforia augmented reality platform, entire new landscapes are opened up in the mobile shopping space. Customers can simply point their mobile at various things and trigger highly-engaging, large-scale interactive media solutions that benefit the brand marketers, retailers, and developers as much as they do the consumer.
Senior Business Director at QCOM, Jay Wright, called it a major step forward for the company’s augmented reality platform and underscored the powerful new capabilities that cloud-base image recognition presents to developers from a monetization standpoint, as well as the long-term brand recognition and customer relationship vectors such engaging content can produce. This technology solution as a whole represent a sort of breakthrough and reverse engineering of the online shopping experience, bringing the granular, data/user-driven online shopping experience to the retail environment, empowering customers while engaging them through content that seeds positive product and shopping experience memories directly in the target market.
The kind of sleek, ultra-modern shopping experiences this tech fusion makes possible are still so nascent that it seems like an entirely new world of possibilities has opened up for brand marketing. Immediate, detailed information is available in an intuitive fashion as users simply point the mobile at signage and branding, setting up a rudimentary associative pattern where actual iconography and branding is seen as a key to unlocking a treasure trove of information. This kind of extremely user-empowering shopping experience is a major hook and the solution is a tantalizing vector for companies like top U.S. apparel designer, manufacturer, and distributor, American Apparel Inc., with whom QCOM has formed a key partnership.
Ever since major mobile industry conference Uplinq’s 2012 keynote from QCOM Board Chairman and CEO, Dr. Paul Jacobs, American Apparel, and Qualcomm have worked together to advance this AR solution, proving to the entire industry the true potential of the technology. This latest announcement of full cloud-based image recognition support only sweetens the deal, making it easier than ever to create as-yet-unseen commerce experiences.
One of the first mobile augmented reality marketing platform developers to integrate Vuforia, Blippar, which has streamlined the entire business of traditional marketing for UK brands/publishers (750k or more users across 150 campaigns) to the point where the term ‘blipp’ has almost become synonymous with AR, is rapidly moving through strenuous trials of the new cloud-based recognition feature. This is a huge win for a company like Blippar, which is going to be able to offer its global portfolio of brands incredible new target market engagement choices.
Currently in developer beta (available by request, or to get more information, through QCOM’s Austria Research Center), this incredible new feature of the Vuforia platform digs deep into QCOM’s bag of computer vision tech competencies and will offer an immediate way for print media and advertising, as well as packaging in general, to take on a whole new interactive dimension. With pricing and commercial availability of the feature set looking for a Fall announcement date this year, QCOM has quite the little engine on their hands and with full support for over 400 smartphones/tablets, in active development with over 300k developers worldwide (landing in some 1k different apps), the new, improved Vuforia platform is going to make even more of a name for this 25-year industry veteran mobile technology innovator.
Or to learn more about the Vuforia platform, visit www.developer.qualcomm.com/vuforia
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
By bringing together cloud-based image recognition and the Vuforia augmented reality platform, entire new landscapes are opened up in the mobile shopping space. Customers can simply point their mobile at various things and trigger highly-engaging, large-scale interactive media solutions that benefit the brand marketers, retailers, and developers as much as they do the consumer.
Senior Business Director at QCOM, Jay Wright, called it a major step forward for the company’s augmented reality platform and underscored the powerful new capabilities that cloud-base image recognition presents to developers from a monetization standpoint, as well as the long-term brand recognition and customer relationship vectors such engaging content can produce. This technology solution as a whole represent a sort of breakthrough and reverse engineering of the online shopping experience, bringing the granular, data/user-driven online shopping experience to the retail environment, empowering customers while engaging them through content that seeds positive product and shopping experience memories directly in the target market.
The kind of sleek, ultra-modern shopping experiences this tech fusion makes possible are still so nascent that it seems like an entirely new world of possibilities has opened up for brand marketing. Immediate, detailed information is available in an intuitive fashion as users simply point the mobile at signage and branding, setting up a rudimentary associative pattern where actual iconography and branding is seen as a key to unlocking a treasure trove of information. This kind of extremely user-empowering shopping experience is a major hook and the solution is a tantalizing vector for companies like top U.S. apparel designer, manufacturer, and distributor, American Apparel Inc., with whom QCOM has formed a key partnership.
Ever since major mobile industry conference Uplinq’s 2012 keynote from QCOM Board Chairman and CEO, Dr. Paul Jacobs, American Apparel, and Qualcomm have worked together to advance this AR solution, proving to the entire industry the true potential of the technology. This latest announcement of full cloud-based image recognition support only sweetens the deal, making it easier than ever to create as-yet-unseen commerce experiences.
One of the first mobile augmented reality marketing platform developers to integrate Vuforia, Blippar, which has streamlined the entire business of traditional marketing for UK brands/publishers (750k or more users across 150 campaigns) to the point where the term ‘blipp’ has almost become synonymous with AR, is rapidly moving through strenuous trials of the new cloud-based recognition feature. This is a huge win for a company like Blippar, which is going to be able to offer its global portfolio of brands incredible new target market engagement choices.
Currently in developer beta (available by request, or to get more information, through QCOM’s Austria Research Center), this incredible new feature of the Vuforia platform digs deep into QCOM’s bag of computer vision tech competencies and will offer an immediate way for print media and advertising, as well as packaging in general, to take on a whole new interactive dimension. With pricing and commercial availability of the feature set looking for a Fall announcement date this year, QCOM has quite the little engine on their hands and with full support for over 400 smartphones/tablets, in active development with over 300k developers worldwide (landing in some 1k different apps), the new, improved Vuforia platform is going to make even more of a name for this 25-year industry veteran mobile technology innovator.
Or to learn more about the Vuforia platform, visit www.developer.qualcomm.com/vuforia
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
PowerSecure International, Inc. (POWR) Receives Contracts Worth $15 Million for Power Projects
PowerSecure International is a leading provider of energy and utility technologies to electric utilities and their industrial, commercial, and institutional customers. The company provides products and services in the areas of: energy efficiency, interactive distributed generation, and utility infrastructure.
The company announced today that it has received $15 million worth of new contracts for its Interactive Distributed Generation (IDG) smart grid power systems and utility infrastructure projects. The new IDG system awards total $10 million and include installations for hospitals and data centers along with pharmaceutical and industrial facilities. The utility infrastructure contracts total $5 million and include transmission system and substation projects for utilities and large industrial customers.
All of these contract awards are for turnkey sales of products and services. PowerSecure states that approximately 80 percent of the revenue is expected to be realized in the second half of 2012, adding to the revenue backlog for the company. The remaining 20 percent of the revenue from these contracts will be recognized during the first half of 2013.
The CEO of PowerSecure, Sidney Hinton, was very pleased with the recent contract awards particularly with the “continuing traction in the hospital, data center, and pharmaceutical markets.” He added that the “sales and marketing teams focused on these customer categories are making terrific progress.” The company continues to be bullish on the opportunities it has to serve these large and growing markets with its proprietary IDG solutions.
For further information about PowerSecure International and its IDG products and services, please visit the company’s website at www.powersecure.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company announced today that it has received $15 million worth of new contracts for its Interactive Distributed Generation (IDG) smart grid power systems and utility infrastructure projects. The new IDG system awards total $10 million and include installations for hospitals and data centers along with pharmaceutical and industrial facilities. The utility infrastructure contracts total $5 million and include transmission system and substation projects for utilities and large industrial customers.
All of these contract awards are for turnkey sales of products and services. PowerSecure states that approximately 80 percent of the revenue is expected to be realized in the second half of 2012, adding to the revenue backlog for the company. The remaining 20 percent of the revenue from these contracts will be recognized during the first half of 2013.
The CEO of PowerSecure, Sidney Hinton, was very pleased with the recent contract awards particularly with the “continuing traction in the hospital, data center, and pharmaceutical markets.” He added that the “sales and marketing teams focused on these customer categories are making terrific progress.” The company continues to be bullish on the opportunities it has to serve these large and growing markets with its proprietary IDG solutions.
For further information about PowerSecure International and its IDG products and services, please visit the company’s website at www.powersecure.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Tuesday, June 26, 2012
Curis, Inc. (CRIS) Announces Clinical Cancer Research Journal to Publish CUDC-907 Data
Curis, a drug development company focused on developing proprietary targeted medicines for cancer treatment, announced today an article regarding CUDC-907 has been published in the journal Clinical Cancer Research. CUDC-907 is an orally-available small molecule drug candidate under development by Curis, and it is designed to simultaneously inhibit PI3K and HDAC. Several members of Curis’ scientific team authored the article, titled “Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase (HDAC) activity and phosphatidylinositol 3-kinase (PI3K) signaling.” The article will be published in the print version of the journal in the near future.
“We are encouraged by the publication of CUDC-907 data in Clinical Cancer Research. We believe that these data support our development strategy for this molecule, under which we plan to initiate a Phase I clinical trial in patients with diffuse large B-cell lymphoma or multiple myeloma later this year,” stated Dan Passeri, Curis President and Chief Executive Officer. “We developed CUDC-907 to target PI3K as well as HDAC, which is known to induce multiple epigenetic modifications affecting signaling networks and also to act synergistically with PI3K inhibitors. The objective of CUDC-907 is to provide for a broad disruption of several pathways that are implicated in hematologic malignancies in order to achieve a better outcome for patients.”
The focus of the article was CUDC-907’s potential for continued development in cancer treatment, specifically in the treatment of hematological cancers. CUDC-907 has shown potent anticancer activity in xenograft models and cultured cancer cells, as well as evidence that it may offer therapeutic benefits for multiple cancer types through broad signaling network disruption. A specific example of these promising capabilities is data showing that CUDC-907 durably inhibits both the primary P13K-AKT-mTOR pathway and also many compensatory signaling molecules which cancer cells often utilize to outmaneuver the mechanisms of single target kinase inhibitors, including RAF, MEK, MAPK, and STAT-3, among others. The scientists at Curis believe that CUDC-907 could possibly deliver improved therapeutic benefit with its simultaneous, sustained disruption of multiple signaling pathways.
Curis’ discovery and development efforts are focused on building a portfolio of small molecule network-targeted inhibitors against a wide range of cancer types. The leading compounds within Curis’ research and development programs are designed to inhibit one or more cancer targets, including EGFR, Her2, and PI3K, as well as the inhibition of histone deacetylase, or HDAC, a validated non-kinase cancer target. Each target combination is chosen for its potential of mechanistic synergy, offering a differentiated, potential breakthrough approach to cancer therapy, intended to disrupt cancer resistance networks.
For more information, please visit www.curis.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We are encouraged by the publication of CUDC-907 data in Clinical Cancer Research. We believe that these data support our development strategy for this molecule, under which we plan to initiate a Phase I clinical trial in patients with diffuse large B-cell lymphoma or multiple myeloma later this year,” stated Dan Passeri, Curis President and Chief Executive Officer. “We developed CUDC-907 to target PI3K as well as HDAC, which is known to induce multiple epigenetic modifications affecting signaling networks and also to act synergistically with PI3K inhibitors. The objective of CUDC-907 is to provide for a broad disruption of several pathways that are implicated in hematologic malignancies in order to achieve a better outcome for patients.”
The focus of the article was CUDC-907’s potential for continued development in cancer treatment, specifically in the treatment of hematological cancers. CUDC-907 has shown potent anticancer activity in xenograft models and cultured cancer cells, as well as evidence that it may offer therapeutic benefits for multiple cancer types through broad signaling network disruption. A specific example of these promising capabilities is data showing that CUDC-907 durably inhibits both the primary P13K-AKT-mTOR pathway and also many compensatory signaling molecules which cancer cells often utilize to outmaneuver the mechanisms of single target kinase inhibitors, including RAF, MEK, MAPK, and STAT-3, among others. The scientists at Curis believe that CUDC-907 could possibly deliver improved therapeutic benefit with its simultaneous, sustained disruption of multiple signaling pathways.
Curis’ discovery and development efforts are focused on building a portfolio of small molecule network-targeted inhibitors against a wide range of cancer types. The leading compounds within Curis’ research and development programs are designed to inhibit one or more cancer targets, including EGFR, Her2, and PI3K, as well as the inhibition of histone deacetylase, or HDAC, a validated non-kinase cancer target. Each target combination is chosen for its potential of mechanistic synergy, offering a differentiated, potential breakthrough approach to cancer therapy, intended to disrupt cancer resistance networks.
For more information, please visit www.curis.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Year-End 1500 for S&P 500? What It Will Take to Crack March Highs
A handful of four primary vectors were drawn up today by the chief investment strategist over at Wells Capital Management, Jim Paulsen, in an interview on his 1,500 target for the S&P 500. In an opening salvo against market crisis neuroses, Paulsen pegged Europe as no longer being a crisis in any proper sense, as the cyclical nature he predicts will be evinced once again at the European Summit this week. The argument is that Europe is basically a “chronic problem.”
Europe is a problem that will be with us for decades, but not one that will derail a global recovery Paulsen argues, pointing more to emerging markets like China and India which have seen bad growth metrics recently, and arguing that the biggest substantial risk to markets at this point, especially the S&P 500, would be a recession in the emerging world. However, the caveat here is obviously last Fall’s strong, accommodative policy measures (easing, etc. as opposed to the late 2010 rate hikes) and the projection that China’s slowdown is already bottoming-out, with a potential nadir being around Q4.
The probability curve is pretty clear to Paulsen on such policy initiatives already getting ahead of the problems at some level, ensuring that the growth potential in emerging markets isn’t something to be too worried about. So if the Euro fear flare up cycle is largely digestible and emerging markets can pull out of the dive easily enough, the other two major factors from Paulsen’s point of view are an under-quantified robustness in the domestic economy coupled with exceptional earnings multiples.
Pointing to $100-level trailing 12-month earnings per share estimate for the S&P 500 in a recent research note, that gives us a price-earnings multiple of around 13 times on trailing earnings (year-end consensus-estimated earnings of around 12.3 times), Paulsen confidently characterized it as a cheap buying opportunity. In fact, he characterized Europe as such and argues generally that too much of an internationalism bent exists, where too much focus on external economies in Europe and China for instance, has upset domestic perspectives.
Paulsen made a strong case that the initial overstatement of U.S. growth data, followed by a huge failure to adequately state the realities of the problem, effectively short-circuited perceptions to a large extent, and he remains very bullish on the domestic economy. People may be selling the market based on low GDP projections but Paulsen argues the U.S. economy is doing “far better than people think,” pointing to his own figure of around 2.5% growth, and underlining several elements that could push it as high as 3%. Stimulating factors cumulatively make this possible according to Paulsen, like mortgage rates under 3.75% (5% last year), money growth at around 10% since Fall (was growing at only 5% a year ago), a dollar that is still off 10% from 2010 highs, falling prices at the pump on fuel, and the recent Case-Shiller 20-city Index (Mar – April period) which shows a 1.3% jump in home prices, breaking a seven-month down trend streak.
Also noted was the inflation rate falling from 4% last Fall to 1.7%, which, alongside China being able to buck the down trend and interest rates being so low amid prime earnings multiples, gives credence to the argument that the S&P 500 could rally through March highs of 1,440 in the second half of the year. Paulsen said that the combination of low interest rates/inflation and choice earnings multiples has never been seen before in the post-War era.
The component vector is tactile to Paulsen who argues that investors aren’t going to care about Europe with a modest domestic recovery and returning emergent growth, with only China’s reliance on Europe as an export market raising concerns.
Looking for a momentum pickup in emerging markets next year, upward revision of GDP targets, a settling-down of financial fear in the Euro zone, and underscoring the attractiveness of the S&P 500 valuations, Paulsen held fast on his 1,500 target for year-end.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Europe is a problem that will be with us for decades, but not one that will derail a global recovery Paulsen argues, pointing more to emerging markets like China and India which have seen bad growth metrics recently, and arguing that the biggest substantial risk to markets at this point, especially the S&P 500, would be a recession in the emerging world. However, the caveat here is obviously last Fall’s strong, accommodative policy measures (easing, etc. as opposed to the late 2010 rate hikes) and the projection that China’s slowdown is already bottoming-out, with a potential nadir being around Q4.
The probability curve is pretty clear to Paulsen on such policy initiatives already getting ahead of the problems at some level, ensuring that the growth potential in emerging markets isn’t something to be too worried about. So if the Euro fear flare up cycle is largely digestible and emerging markets can pull out of the dive easily enough, the other two major factors from Paulsen’s point of view are an under-quantified robustness in the domestic economy coupled with exceptional earnings multiples.
Pointing to $100-level trailing 12-month earnings per share estimate for the S&P 500 in a recent research note, that gives us a price-earnings multiple of around 13 times on trailing earnings (year-end consensus-estimated earnings of around 12.3 times), Paulsen confidently characterized it as a cheap buying opportunity. In fact, he characterized Europe as such and argues generally that too much of an internationalism bent exists, where too much focus on external economies in Europe and China for instance, has upset domestic perspectives.
Paulsen made a strong case that the initial overstatement of U.S. growth data, followed by a huge failure to adequately state the realities of the problem, effectively short-circuited perceptions to a large extent, and he remains very bullish on the domestic economy. People may be selling the market based on low GDP projections but Paulsen argues the U.S. economy is doing “far better than people think,” pointing to his own figure of around 2.5% growth, and underlining several elements that could push it as high as 3%. Stimulating factors cumulatively make this possible according to Paulsen, like mortgage rates under 3.75% (5% last year), money growth at around 10% since Fall (was growing at only 5% a year ago), a dollar that is still off 10% from 2010 highs, falling prices at the pump on fuel, and the recent Case-Shiller 20-city Index (Mar – April period) which shows a 1.3% jump in home prices, breaking a seven-month down trend streak.
Also noted was the inflation rate falling from 4% last Fall to 1.7%, which, alongside China being able to buck the down trend and interest rates being so low amid prime earnings multiples, gives credence to the argument that the S&P 500 could rally through March highs of 1,440 in the second half of the year. Paulsen said that the combination of low interest rates/inflation and choice earnings multiples has never been seen before in the post-War era.
The component vector is tactile to Paulsen who argues that investors aren’t going to care about Europe with a modest domestic recovery and returning emergent growth, with only China’s reliance on Europe as an export market raising concerns.
Looking for a momentum pickup in emerging markets next year, upward revision of GDP targets, a settling-down of financial fear in the Euro zone, and underscoring the attractiveness of the S&P 500 valuations, Paulsen held fast on his 1,500 target for year-end.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Lantronix, Inc. (LTRX) Signs Distribution Partnership for xPrintServer with Micro Center
Lantronix, a leading global provider of smart M2M connectivity solutions, announced a partnership with Micro Center to market and sell the award-winning xPrintServer™ Network Edition, iOS printing solution. The xPrintServer Network Edition will retail for $149.99 MSRP.
“We are thrilled to have Micro Center as the first retail outlet for our award-winning xPrintServer,” said Rob Robinson, Vice President of Worldwide Sales for Lantronix. “We are aggressively working toward expanding our global retail, etail, and traditional distribution networks, and Micro Center is a prime example of a retailer targeting IT decision makers for our xPrintServer network edition, as well as future editions.”
“The xPrintServer is a natural fit for our computer and electronics superstore,” said Kevin Jones, Vice President, Merchandising for Micro Center. “Our customer base is primarily comprised of IT professionals, who come to us looking for the latest technology solutions for their enterprise. We are pleased to be the first retailer to carry the xPrintServer, and look forward to its success in the retail space.”
Lantronix, headquartered in Irving, CA, offers smart and easy to integrate, secure M2M communication technologies that simplify access and communication with and between electronic devices like computers, PDAs, and smartphones. Lantronix connectivity solutions enable sharing data between devices and applications to empower businesses to make better decisions based on real-time information. Lantronix was founded in 1989 and serves some of the largest medical, security, industrial, and building automation, transportation, retail/POS, financial, government, consumer electronics/appliances, IT/data center, and pro-AV/signage entities in the world. These businesses gain a competitive advantage by generating new revenue streams, improving productivity and increasing efficiency and profitability.
For more information visit www.lantronix.com
Micro Center, one of the companies of privately-held Micro Electronics, Inc., is a large computer retailer with both brick-and-mortar retail locations and online capabilities. Its value proposition is to be “The Ultimate Computer Store” and offers customers more selection, better service, an enjoyable and interactive shopping atmosphere, and assistance from a professional and technically trained in-store staff. The company offers over 35,000 types of products and is ranked 301st on Forbes 2004 Top Private Companies list.
For more information, visit www.microcenter.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We are thrilled to have Micro Center as the first retail outlet for our award-winning xPrintServer,” said Rob Robinson, Vice President of Worldwide Sales for Lantronix. “We are aggressively working toward expanding our global retail, etail, and traditional distribution networks, and Micro Center is a prime example of a retailer targeting IT decision makers for our xPrintServer network edition, as well as future editions.”
“The xPrintServer is a natural fit for our computer and electronics superstore,” said Kevin Jones, Vice President, Merchandising for Micro Center. “Our customer base is primarily comprised of IT professionals, who come to us looking for the latest technology solutions for their enterprise. We are pleased to be the first retailer to carry the xPrintServer, and look forward to its success in the retail space.”
Lantronix, headquartered in Irving, CA, offers smart and easy to integrate, secure M2M communication technologies that simplify access and communication with and between electronic devices like computers, PDAs, and smartphones. Lantronix connectivity solutions enable sharing data between devices and applications to empower businesses to make better decisions based on real-time information. Lantronix was founded in 1989 and serves some of the largest medical, security, industrial, and building automation, transportation, retail/POS, financial, government, consumer electronics/appliances, IT/data center, and pro-AV/signage entities in the world. These businesses gain a competitive advantage by generating new revenue streams, improving productivity and increasing efficiency and profitability.
For more information visit www.lantronix.com
Micro Center, one of the companies of privately-held Micro Electronics, Inc., is a large computer retailer with both brick-and-mortar retail locations and online capabilities. Its value proposition is to be “The Ultimate Computer Store” and offers customers more selection, better service, an enjoyable and interactive shopping atmosphere, and assistance from a professional and technically trained in-store staff. The company offers over 35,000 types of products and is ranked 301st on Forbes 2004 Top Private Companies list.
For more information, visit www.microcenter.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Scio Diamond Technology Corp. (SCIO) Reports First Successful Run for Diamond Growing Reactors
Scio Diamond Technology employs a patent-protected chemical vapor deposition process to produce high-quality, single-crystal diamonds in a controlled laboratory setting. These lab-grown or cultivated diamonds have the identical chemical, physical, and optical properties as natural diamonds found in the earth. The company intends to sell artificial diamonds to the both the jewelry and the technology sectors.
The company reported today that the first full production run using its S3532 technology of five diamond growing reactors was extremely successful. The five growers ran an average of 179 hours each, producing over 220 gross carats of diamonds. Scio Diamond’s CEO Joe Lancia called it “yet another milestone passed on Scio’s roadmap to the mass production of diamond.”
Two more reactors are scheduled to enter initial full production runs in the next week. Scio expects the balance of the 10 reactors to be in full production by the end of its fiscal second quarter. As production moves toward a “normal” operating schedule, the company will be concentrating on a parallel growth in its diamond fabrication capabilities. These will include precise laser cutting and polishing operations to take the rough-cut diamond to the final product stage.
As Scio eventually builds a self-sustaining seed stock, the company continues to work with clients on their specific diamond requirements. This is a very important point. Scio’s believes it must not just produce diamonds, but produce diamonds to the customers’ specifications, and to do so reliably and with scalability.
To find out more about Scio Diamond Technology and its approach to diamond production, please visit its Web site at www.sciodiamond.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company reported today that the first full production run using its S3532 technology of five diamond growing reactors was extremely successful. The five growers ran an average of 179 hours each, producing over 220 gross carats of diamonds. Scio Diamond’s CEO Joe Lancia called it “yet another milestone passed on Scio’s roadmap to the mass production of diamond.”
Two more reactors are scheduled to enter initial full production runs in the next week. Scio expects the balance of the 10 reactors to be in full production by the end of its fiscal second quarter. As production moves toward a “normal” operating schedule, the company will be concentrating on a parallel growth in its diamond fabrication capabilities. These will include precise laser cutting and polishing operations to take the rough-cut diamond to the final product stage.
As Scio eventually builds a self-sustaining seed stock, the company continues to work with clients on their specific diamond requirements. This is a very important point. Scio’s believes it must not just produce diamonds, but produce diamonds to the customers’ specifications, and to do so reliably and with scalability.
To find out more about Scio Diamond Technology and its approach to diamond production, please visit its Web site at www.sciodiamond.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Monday, June 25, 2012
Synthesis Energy Systems, Inc. (SYMX) Tests of Turkish Lignite Coals a Success, Syngas Plants Planned
Synthesis Energy Systems, whose proprietary U-GAS® clean energy (fluidized bed gasification) technology, equipment, and engineering services have rapidly gained acclaim in the energy sector for helping turn low-cost feedstock/biomass into energy and chemical products, reported positive lab-scale output data today, with the completion of testing on three Turkish lignite coal targets earmarked for clean coal power generation projects.
Under development by one of Turkey’s largest independent power project (IPP) developers, Tuten Ltd., the clean coal infrastructure development is being sponsored by a major Turkish utility company intent on modernizing their production footprint. Also part of the project will be Slovakian EPC firm (engineering, procurement, and constriction), Istroenergo Group.
The testing was performed by SYMX at the Des Plaines, Illinois, laboratories of Gas Technology Institute (from whom the company licenses U-GAS), showing 96 to 99.5% single-pass carbon conversions rates on each of the coals.
This is superb news for the project development team, which has devised an ingenious conceptual-level design to provide 50 to 100 MW generation modules based on the cheap, abundant lignite coal. The genius of the design stems from a powerful integration of the gasification technology with a General Electric LM2500+G4 aeroderivative gas turbine.
The amazing diversity, industrial-quality robustness, and general availability provided by GE’s LM2500+G4 turbine is ideal for this sort of syngas application and the SYMX technology is at the heart of the development team’s solution. With viability data in hand, the company is all the more eager to move the project forward, encouraged by a team assembled of some of the top players in the region/sector.
Founding partner of Turkish IPP giant Tuten, Tarik Tuten, hailed the successful testing as a clear sign that advancement to the next stage of the project for Tuten’s utility customer in Turkey will be seen by the sponsor/stakeholders as something in which they can easily place their confidence. Tuten brings a mountain of expertise developing gas-fired IPPs in the 120 to 1200 MW range to the clean coal space and with turn-key versatility experts Istroenergo also on board, it’s no wonder the development team (and their solution) is already drawing accolades.
President and CEO of Aeroderivative Gas Turbines for GE Power & Water, Darryl Wilson, was very pleased to see this perfect use of the LM2500+G4 turbine, for completing the syngas loop from low grade lignite coal, tipping his hat to this winning solution the team has devised.
It’s huge news for SYMX really and the sector as well; after all, such low grade coal like this Turkish lignite is abundant all over the planet, affording generally low recovery costs as well. There is a massive market for such solutions and the underlying dynamics are exceptionally attractive, from lowering dependency on imported energy sources, to better overall domestic resource utilization, and the squeaky clean environmental profile is hard to beat.
South Africa and Turkey are perfect markets for the kinds of solutions being put together by the team around GE technology and the incredible advancements made possible by SYMX’s U-GAS technology are still just the first steps of a better, cleaner, and more efficient energy future. Because the U-GAS technology has a maximum fuel window, able to process all ranks of coal, including coal waste and biomass/feedstock, and is engineered for smaller scale applications, the technology can roll out very fast. Rapid development of such critical infrastructure in developing markets around underutilized, available resources is a recipe for serious revenue momentum.
To get more information about Synthesis Energy Systems’ technology, or the developments in Turkey, head on over to the company’s website at: www.SynthesisEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Under development by one of Turkey’s largest independent power project (IPP) developers, Tuten Ltd., the clean coal infrastructure development is being sponsored by a major Turkish utility company intent on modernizing their production footprint. Also part of the project will be Slovakian EPC firm (engineering, procurement, and constriction), Istroenergo Group.
The testing was performed by SYMX at the Des Plaines, Illinois, laboratories of Gas Technology Institute (from whom the company licenses U-GAS), showing 96 to 99.5% single-pass carbon conversions rates on each of the coals.
This is superb news for the project development team, which has devised an ingenious conceptual-level design to provide 50 to 100 MW generation modules based on the cheap, abundant lignite coal. The genius of the design stems from a powerful integration of the gasification technology with a General Electric LM2500+G4 aeroderivative gas turbine.
The amazing diversity, industrial-quality robustness, and general availability provided by GE’s LM2500+G4 turbine is ideal for this sort of syngas application and the SYMX technology is at the heart of the development team’s solution. With viability data in hand, the company is all the more eager to move the project forward, encouraged by a team assembled of some of the top players in the region/sector.
Founding partner of Turkish IPP giant Tuten, Tarik Tuten, hailed the successful testing as a clear sign that advancement to the next stage of the project for Tuten’s utility customer in Turkey will be seen by the sponsor/stakeholders as something in which they can easily place their confidence. Tuten brings a mountain of expertise developing gas-fired IPPs in the 120 to 1200 MW range to the clean coal space and with turn-key versatility experts Istroenergo also on board, it’s no wonder the development team (and their solution) is already drawing accolades.
President and CEO of Aeroderivative Gas Turbines for GE Power & Water, Darryl Wilson, was very pleased to see this perfect use of the LM2500+G4 turbine, for completing the syngas loop from low grade lignite coal, tipping his hat to this winning solution the team has devised.
It’s huge news for SYMX really and the sector as well; after all, such low grade coal like this Turkish lignite is abundant all over the planet, affording generally low recovery costs as well. There is a massive market for such solutions and the underlying dynamics are exceptionally attractive, from lowering dependency on imported energy sources, to better overall domestic resource utilization, and the squeaky clean environmental profile is hard to beat.
South Africa and Turkey are perfect markets for the kinds of solutions being put together by the team around GE technology and the incredible advancements made possible by SYMX’s U-GAS technology are still just the first steps of a better, cleaner, and more efficient energy future. Because the U-GAS technology has a maximum fuel window, able to process all ranks of coal, including coal waste and biomass/feedstock, and is engineered for smaller scale applications, the technology can roll out very fast. Rapid development of such critical infrastructure in developing markets around underutilized, available resources is a recipe for serious revenue momentum.
To get more information about Synthesis Energy Systems’ technology, or the developments in Turkey, head on over to the company’s website at: www.SynthesisEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Cardium Therapeutics, Inc. (CXM) Looking to Finish-out 2012 Objectives Under the Guidance of Veteran Management Team
Cardium Therapeutics utilizes a growth strategy based on acquisition of businesses with the potential to address unmet medical needs. The company’s investment portfolio includes the Tissue Repair Company; Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing and cardiovascular indications; and the MedPodium healthy lifestyle product platform. Cardium’s acquisition strategy is executed under the guidance of an eight-member team with decades of combined experience spanning the healthcare sector.
Between the two of them, Cardium Therapeutics co-founders Christopher J.Reinhard and Dr. Tyler M. Dylan-Hyde (Ph.D., J.D.) have experience working for numerous biotech companies, an industrial and manufacturing group, and in the development of biologics and devices for cardiovascular and ischemic diseases, among others. Reinhard has served as chairman of the board, CEO, president, and treasurer since the company’s inception in December 2003. Dr. Dylan-Hyde is Cardium’s director, chief business officer, general counsel, executive vice president, and secretary, as well as company co-founder.
Heading the company’s fiscal responsibilities is Cardium Therapeutics CFO Dennis M. Mulroy, CPA, who joined the company in November 2005. In addition to his roles with several company subsidiaries, he was also previously appointed CFO of three publicly traded biotech companies not affiliated with Cardium Therapeutics. Additionally, Mulroy was employed with Ernst & Young in San Diego, Calif.
Dr. Gabor M. Rubanyi, (M.D., Ph.D.), is Cardium Therapeutics chief scientific officer. Before taking the position in June 2006, Dr. Rubanyi provided consulting services to the company. Prior to that, he served various companies as vice president, adjunct professor, and associate professor. Dr. Rubanyi is the author or co-author of 22 books and more than 325 research articles. He serves as an editorial board member to several biomedical journals and is the founder of biomed journal Endothelium.
Determining the value of a potential acquisition target takes business savvy and experience. Cardium Therapeutics is backed by Mark McCutchen, who is vice president of business development for both Cardium Therapeutics and Tissue Repair Company. He has more than 15 years of financial and business management experience in the life sciences industry and has overseen seven rounds of venture and private financings totaling more than $60 million. Among other achievements, he also has experience in equity and debt transactions for high technology and life science companies.
Also integral to seeking out acquisitions in the healthcare sector is hands-on knowledge of the medical field itself. Dr. Robert L. Engler serves as Cardium Therapeutics’ chief medical advisor and was the co-founder of Collateral Therapeutics, where he was a director, vice president, and medical director at various stages. He is also professor of Medicine Emeritus at the University of California, San Diego. Among other previous endeavors, Dr. Engler was a clinical cardiologist and associate chief of staff for research and development at the Veterans’ Affairs Medical Center. He is director of publicly traded biotech company, Halozyme Therapeutics.
Cardium Therapeutics’ management team comprises every aspect of the healthcare sector, including regulations. Ted Williams is the vice president of Cardium Therapeutics’ manufacturing and technical operations, where he lends his more than 25 years of professional experience in FDA-regulated environments of biopharm process development, medical device development, quality control/quality assurance, and more. He also serves as vice president of Tissue Repair’s manufacturing and technical operations, and held the same position at InnerCool Therapies until its sale to Royal Philips Electronics in July 2009. Prior to joining Cardium Therapeutics, Williams held various roles, including director of research operations, process technologies, and quality systems; senior manager of quality systems; manager of quality control; supervisor of quality control; and chief microbiologist and supervisor.
Dr. Lois A. Chandler, vice president of biologics development for Cardium Therapeutics, has 17 years of professional experience in biopharmaceutical design and clinical development, chemistry, manufacturing and controls, quality control, and custom DNA vector design. She has also served as associate director of vector development for a company that developed targeted viral and non-viral DNA therapeutics for dermal, cardiovascular, and orthopedic tissue repair; as a senior scientist of molecular biology.
Backed by a seasoned and diverse management team, the company looks forward to achieving its goals for 2012, which include its plans to advance commercialization of its new Excellagen® advanced, physician-use wound care product through strategic partners in the U.S. and internationally; develop new product extensions based on Excellagen’s formulated collagen product platform for additional wound healing applications; advance its ASPIRE Generx® clinical study at leading medical centers in the Russian Federation for patients with advanced coronary disease; introduce additional product line extensions and broaden national distribution of the company’s MedPodium® healthy lifestyle product platform; and continue to identify and evaluate businesses, product opportunities and technologies complementary with Cardium Therapeutics’ long-term business, and acquisition strategy.
To learn more about the company, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Between the two of them, Cardium Therapeutics co-founders Christopher J.Reinhard and Dr. Tyler M. Dylan-Hyde (Ph.D., J.D.) have experience working for numerous biotech companies, an industrial and manufacturing group, and in the development of biologics and devices for cardiovascular and ischemic diseases, among others. Reinhard has served as chairman of the board, CEO, president, and treasurer since the company’s inception in December 2003. Dr. Dylan-Hyde is Cardium’s director, chief business officer, general counsel, executive vice president, and secretary, as well as company co-founder.
Heading the company’s fiscal responsibilities is Cardium Therapeutics CFO Dennis M. Mulroy, CPA, who joined the company in November 2005. In addition to his roles with several company subsidiaries, he was also previously appointed CFO of three publicly traded biotech companies not affiliated with Cardium Therapeutics. Additionally, Mulroy was employed with Ernst & Young in San Diego, Calif.
Dr. Gabor M. Rubanyi, (M.D., Ph.D.), is Cardium Therapeutics chief scientific officer. Before taking the position in June 2006, Dr. Rubanyi provided consulting services to the company. Prior to that, he served various companies as vice president, adjunct professor, and associate professor. Dr. Rubanyi is the author or co-author of 22 books and more than 325 research articles. He serves as an editorial board member to several biomedical journals and is the founder of biomed journal Endothelium.
Determining the value of a potential acquisition target takes business savvy and experience. Cardium Therapeutics is backed by Mark McCutchen, who is vice president of business development for both Cardium Therapeutics and Tissue Repair Company. He has more than 15 years of financial and business management experience in the life sciences industry and has overseen seven rounds of venture and private financings totaling more than $60 million. Among other achievements, he also has experience in equity and debt transactions for high technology and life science companies.
Also integral to seeking out acquisitions in the healthcare sector is hands-on knowledge of the medical field itself. Dr. Robert L. Engler serves as Cardium Therapeutics’ chief medical advisor and was the co-founder of Collateral Therapeutics, where he was a director, vice president, and medical director at various stages. He is also professor of Medicine Emeritus at the University of California, San Diego. Among other previous endeavors, Dr. Engler was a clinical cardiologist and associate chief of staff for research and development at the Veterans’ Affairs Medical Center. He is director of publicly traded biotech company, Halozyme Therapeutics.
Cardium Therapeutics’ management team comprises every aspect of the healthcare sector, including regulations. Ted Williams is the vice president of Cardium Therapeutics’ manufacturing and technical operations, where he lends his more than 25 years of professional experience in FDA-regulated environments of biopharm process development, medical device development, quality control/quality assurance, and more. He also serves as vice president of Tissue Repair’s manufacturing and technical operations, and held the same position at InnerCool Therapies until its sale to Royal Philips Electronics in July 2009. Prior to joining Cardium Therapeutics, Williams held various roles, including director of research operations, process technologies, and quality systems; senior manager of quality systems; manager of quality control; supervisor of quality control; and chief microbiologist and supervisor.
Dr. Lois A. Chandler, vice president of biologics development for Cardium Therapeutics, has 17 years of professional experience in biopharmaceutical design and clinical development, chemistry, manufacturing and controls, quality control, and custom DNA vector design. She has also served as associate director of vector development for a company that developed targeted viral and non-viral DNA therapeutics for dermal, cardiovascular, and orthopedic tissue repair; as a senior scientist of molecular biology.
Backed by a seasoned and diverse management team, the company looks forward to achieving its goals for 2012, which include its plans to advance commercialization of its new Excellagen® advanced, physician-use wound care product through strategic partners in the U.S. and internationally; develop new product extensions based on Excellagen’s formulated collagen product platform for additional wound healing applications; advance its ASPIRE Generx® clinical study at leading medical centers in the Russian Federation for patients with advanced coronary disease; introduce additional product line extensions and broaden national distribution of the company’s MedPodium® healthy lifestyle product platform; and continue to identify and evaluate businesses, product opportunities and technologies complementary with Cardium Therapeutics’ long-term business, and acquisition strategy.
To learn more about the company, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)